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Gene expression data repositories provide large and ever increasing data for 
secondary use by translational informatics methods.  For example, Gene Expression 
Omnibus (GEO) houses over 37,000 experiments with the goal of supporting further 
research.  To use these published results in a larger meta-analysis, consolidation of the 
data are needed; however, the data are largely unstructured, thus hindering data 
integration efforts.  Here, I propose the use of a novel pipeline, Ontology Based Data 
Integration (OBDI), which uses an ontological approach to combine the samples across 
multiple GEO experiments. The ODBI pipeline uses machine learning algorithms that 
permit researchers to consolidate and analyze data across GEO experiments.   
Here, I demonstrate how using an ontological approach to integrate samples 
across experiments can be used to explore the immune response at a molecular level.  
As part of this process, a Web Ontology Language (OWL) was developed for each data 
platform used.  OWL serves as a core component in successfully processing different 
sample types.  Immunological experiments from GEO were consolidated to evaluate 
this methodology.  The experiments included samples analyzed on expression arrays, 
BeadChips, and sequencing technologies.  The integration of a complex biological 
system and the incorporation of different biological data types will validate the potential 
of OBDI.  
  
iv 
The nature of biological data is highly dimensional.  OBDI incorporates tools 
and techniques that can handle the analysis of various biological data.  The machine 
learning analysis performed within the OBDI pipeline successfully evaluated the newly 
annotated experiments and provides insights that can be further explored.   
 The OBDI pipeline can help researchers annotate experiments using ontologies 
and analyze the annotated experiments.  To successfully build the pipeline, ontologies 
served as the backbone of integrating samples from GEO Series records into machine 
learning experiments using ML-Flex. By using the OBDI pipeline, researchers can 
access the uncurated experiments from GEO (GEO Data Series) and annotate the data 
using the terms in the ontologies.  This mechanism allows for the organization of data 
sets in relationship to new experiments independent of GEO’s GDS curation process.  
The OBDI system allows ontologies to grow organically around a cluster of 
experiments.  These experiments are then further analyzed in ML-Flex using machine 
learning algorithms. The curated experiments are analyzed in silico and the 
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Performing differential gene expression analysis provides insight into the 
biomolecular mechanisms that play a role in cellular process that are explored in both 
laboratory and clinical research. Gene expression data from microarray experiments and 
sequencing experiments are available in public repositories. These repositories allow 
researchers to upload their experiments, making the raw data, the metadata and the 
associated journal publications available to the scientific community. There is 
tremendous potential for novel discoveries that can be found by integrating studies from 
public repositories and performing meta-analysis on the integrated data sets. Current 
efforts are focused on increasing the data stored to public repositories; however, the 
efforts to make data usable across experiments is lacking. With an exponential increase 
of data being generated, there is a need to improve the ability to combine data in order 
to identify novel findings that were not possible with smaller data sets or were not the 
focus of original experiment.  
 When integrating data, it is important to take into account the biological and/or 
the clinical complexity associated to specific samples being combined. Although 
repositories store the biomedical metadata associated to each study, there is a lack of 
standardized vocabulary that is used to describe metadata; hence, parsing the metadata 
are not sufficient for tackling biological complexity during data integration. The 





laboratories and users are not provided with a standardized way to enter biological 
information [1-3]. An ontological approach is one way of handling metadata 
inconsistencies. Ontologies provide a standardized way of storing the metadata, and 
making the information machine readable [4].  
Once the data are integrated, the meta-analysis of the newly integrated set can 
lead to new insights.  Performing differential expression analysis on integrated data sets 
is an effective way of exploring how a set of genes, are regulated differently across a 
given set of variables. Genes can be further clustered based on their biological 
responses they share to treatments, diseases, and different time points. The set of 
variable can be classified using a data driven approach. Machine learning algorithm can 
be used to classify variables or cluster genes into different groups. Machine learning 
focuses on prediction that is based on previous knowledge or on new information 
learned from a subset of the curated data set. Analyzing integrated data sets can lead to 
a more comprehensive model because integration across studies increases the number of 
variables that are being assessed.     
In this study, a novel pipeline is proposed that integrates samples from a public 
repository while maintaining consistent representations to generate novel data sets. The 
analysis of these data sets can lead to generating hypotheses with targeted features that 
can be tested in a laboratory setting. The ontological representations in this pipeline can 
be re-used, as more samples are available in the public repositories. The consistent 
representation that can be achieved through ontologies allows for modeling high 
dimensional data to find new insights that generate experiments using a hypothesis 





allowing users to modify the protocol within the ontologies. This unique feature in the 
proposed pipeline can help reproduce the results in this study. To validate the pipeline, 
gene expression data from laboratory experiments are integrated and used to generate 
hypotheses that explore a specific biomolecular mechanism. The results generated from 
the newly integrated data sets can be translated to the bench in order to help further 
biomedical research. The pipeline provides an example of how research in translational 
science can transform an in silico model to aid hypothesis generation that may be 




2. DISSERTATION AIMS AND OBJECTIVES 
This dissertation proposes and implements an ontology dependent pipeline to 
extend the field of data integration. This pipeline, called Ontology Based Data Integration 
(OBDI), helps solve major hurdles that occur when integrating data across Gene 
Expression Omnibus (GEO) [5-7] experiments. The information in experiments is 
incorporated into ontologies; therefore, aiding the evolving nature of new submission and 
meta-analysis being performed. New integrated data sets created through OBDI can 
provide new information and potential targets. The novel OBDI pipeline will provide a 
means to increase sample size and offers mechanisms to build a more comprehensive 
view of knowledge domains.  OBDI extends biological information using ontologies to 
facilitate the exploration of complex biological spaces by annotating novel experiments.  
Using ontologies, the OBDI pipeline is built such that: [1] data are downloaded 
from GEO, [2] reorganized into biologically relevant machine learning experiments that 
[3] exist outside the GEO framework, and [4] finally, these novel experiments are 
analyzed using machine learning algorithms.  By integrating the ontologies, workflow, 
and the results, a comprehensive model is generated. With the methodologies 
incorporated in OBDI a comprehensive model can be replicated, examined, modified, and 
extended with additional knowledge. 
The primary motivation of this project was to generate a comprehensive model 
representation that is supported by the OBDI pipeline.  The methodologies in OBDI are 





experiments.  Other laboratories can replicate the described methodology in order to 
successfully integrate GEO experiments, and thoroughly evaluate a biological space from 
a data driven approach.  The OBDI pipeline will allow informaticians to curate new 
experiments from preexisting GEO experiments thus adding new knowledge that may 
help move research at the bench. 
 
Aims 
The components of the OBDI pipeline combine high throughput samples that 
have never been integrated in previous experiments, allowing users to generate a 
hypothesis driven immunological model. This integrated model will support the bench 
researcher in exploring how the immune system interacts at a molecular level. Based on 
the motivation and the objectives described in the previous sections, the following 
research aims were evaluated. 
• Aim 1: Develop an Ontology Based Data Integration (OBDI) pipeline using the 
Java programming language for preprocessing, integrating and performing meta- 
analysis on high throughput data from GEO 
• Aim 2: Evaluate four annotated experiments, generated by integrating GEO 
experiments, and perform machine learning analysis as implemented in ML-Flex 
• Aim 3: Extend machine learning results in AIM 2 by generating a well-integrated 
model for bench researchers by incorporating prior knowledge that is gathered 






• Aim 4: Generalize predictive model from Experiment 1 to other GEO 
experiments that explore the immune system response in order to create a more 
comprehensive model that could be applied in a laboratory setting 
The purpose of Aim 1 is to build a pipeline that allows the integration of GEO 
experiments and various tools to analyze high throughput data. Ontologies are developed 
to unify the vocabulary used to describe GEO experiments.  Each annotated experiment is 
associated with the respective ontology and the various elements of the experiment are 
stored as OWL entities. Multiple data sets are related to generate curated experiments 
constrained by specified prior knowledge encoded within the ontology.  Integrating 
samples using ontologies allows researchers to not only replicate this approach, but also 
extend upon existing ontologies. More biological and clinical information from GEO can 
be added to the ontologies; therefore reducing the barrier to curate newer data sets. 
Reasoning over the ontologies promotes the integration of samples and analysis of 
curated experiments. Using ontologies within the OBDI pipeline allows maintaining 
consistency as more samples are added to GEO and other public repositories. By building 
the ODBI pipeline, I will [1] resolve some complexities around data integration and [2] 
successfully build in silico experiments, outside the GEO framework, that can be 
analyzed using machine learning algorithms. 
In Aim 2 machine learning algorithms are implemented to perform analysis on 
four experiments. For the analysis component, ML-Flex is incorporated within OBDI. To 
perform in silico analysis, ML-Flex is provided with a configuration file that contains 
analytical protocols. Information needed to perform in silico analysis is stored as 





ontological representations to store the analysis component allows users to reproduce the 
results, change parameters, and maintain consistency when adding more samples to the 
curated experiments.  
Aim 3 includes biological information retrieved from different sources that 
extends the in silico analysis by incorporating biological information. The genes in the 
predictive model are grouped together based on preexisting knowledge of biological 
pathways.  This knowledge is gathered by various sources; however, the pathway 
information primarily comes from the knowledge stored in the Kyoto Encyclopedia of 
Genes and Genomes (KEGG).  A heatmap is used to display the comparative model and 
the expression of a subset of individual genes is depicted with boxplots.  Visualizing the 
results of the machine learning analysis provides insight into how certain immune system 
response genes are differentially expressed. By integrating samples that were previously 
analyzed in silos, I am able to generate results that were overlooked due to the lack of 
combing similar samples into a single experiment. Finding biological relevance in newly 
combined experiments depicts how OBDI can generate novel insights to be validated at 
the bench.  
In Aim 4, I show how OBDI is used to generate a comprehensive hypothesis that 
can be tested using data from other cell types and clinical experiments. Focusing the 
analysis on samples related to a specific research domain validates the OBDI pipeline. 
Multiple in silico experiments are analyzed to explore the biomolecular interactions in the 
field of cancer immunotherapy. To generate a comprehensive model, queries in GEO had 
to be setup in a logical manner. Incorporating more experiment from GEO that are 





hypothesis generation through ontological representations and meta-analysis of integrated 
experiments. By incorporating more experiments from GEO, I am also able to design 
OBDI as a flexible framework that incorporates other data types, such as, sequencing 
data from NGS experiments. In AIM 4, OBDI is used to derive models from in silico 
analysis and also extends integration methods by incorporating other data types.   
 The goal of creating the OBDI pipeline is to study a complex environment such 
as immune system response in order to generate new knowledge and help bench 
researchers design targeted experiments. With the use of ontologies, samples across GEO 
experiments are annotated to generate new experiments that support research in 
translational science. Experiments analyzed in this dissertation using OBDI support 
research at the bench and may lead to new findings that can help improve immune system 






Biomedical data can be successfully stored in online repositories; however, the 
backlog of integrated data sets impedes the research in translational science. The 
expanding sources of data offer new opportunities for discoveries and validation of 
previous research. Researchers can archive their experimental data samples by submitting 
them to a data repository.  In addition to the raw data, a researcher can include 
publications and metadata associated with the experiment.  Submitted data can be kept 
private until the experimental results are published in a manuscript, after which the data 
are made available for public use [5].  Making experimental data publically available via 
open repositories allows for furthering research by querying submissions and reusing the 
data.   
Some of the commonly used data repositories are: ArrayExpress, Sequence Read 
Archive (SRA), and Gene Expression Omnibus (GEO) [5-7].  ArrayExpress is a database 
housed at the European Bioinformatics Institute (EBI) that stores gene expression 
microarray data and high throughput sequencing data [6].  SRA is managed by the 
National Center for Biotechnology Information (NCBI) and primarily stores raw Next 
Generation Sequencing (NGS) data [5].  GEO is housed at NCBI and contains a vast 
range of data, including, gene expression, SNP arrays, protein arrays and NGS [7]. The 
curators of these three databases collaborate with each other to share data structures and 




This study focuses on retrieving and organizing high-throughput data across 
different experiments, such that, it allows new development in the field of basic science 
and medicine. Samples integrated in this study are constrained to a single repository, 
GEO.  
 
Gene Expression Omnibus (GEO) 
 
GEO is a large database that stores over 1 million samples from high throughput 
experiments. When submitting data to GEO, researchers can use several formats to enter 
information related to their experiment.  The submission format options include, 
spreadsheets, Simple Omnibus Format in Text (SOFT) and Extensible Markup Language 
(XML).  Spreadsheets work best when researchers want to quickly describe their study.  
The spreadsheet contains the metadata and the spreadsheet is bundled with the raw data 
files for submission.  This submission method is recommended for most users.  If the data 
are already in the GEO database, the SOFT or XML format is recommended for 
submission.  SOFT is a line based plain text format that can be readily generated from 
common database applications, such as MySQL [7, 8]. 
 In GEO the submitted data are stored as a GEO Series (GSE) record and are 
assigned a GSE accession number. GEO Series records may contain samples that are 
analyzed on different platforms and vary in their experimental properties. The staff at 
GEO reassembles the original submissions into curated GEO DataSets that are given a 
GEO DataSet (GDS) accession number. Samples identified by a single GDS number are 
analyzed on the same platform, and share similar array elements. This makes 
organization, normalization, and processing equivalent across samples within a DataSet. 




different identifiers (GPLxxx and GSMxxx, respectively). Both GSE and GDS are 
searchable using the GEO interface; only the GDS can be used to perform GEO’s 
advanced data display and analysis tools.  Using these tools for the curated DataSets, a 
researcher can query gene names, visualize charts and perform clustering analysis. Meta-
analysis within GEO includes differential expression analysis performed using GEO2R. 
To identify genes that have a similar response pattern, hierarchical clustering can be used 
within GEO. Due to the large volume of data submissions and the inability to reassemble 
all Series records, there is a backlog of converting original submissions into curated 
DataSets. For instance, in Figure 3.1 only 64,919 samples are curated into GEO DataSets 
[7], leaving 992,559 uncombined samples that cannot be analyzed using GEO based tools 
(GEO2R, Hierarchical Clustering).  
Once the experiments are submitted, the MIAME (Minimum Information About a 
Microarray Experiment) Notation in Markup Language (MINiML) formatted files can be 
downloaded to access metadata.  MINiML is a data exchange format used in GEO that 
captures the minimum information required when describing a high throughput 
experiment, in addition to any other information supplied by the submitter [7]. To 
analyze high throughput data at a genomic level different manufactures, such as 
Affymetrix, and Illumina, have developed competing technologies [8].  In expression 
analysis, individual assays differ in the type of probes being used (cDNA, oligonucleotide 
size, probe I.D, etc.), the hybridization methodology (specific versus nonspecific) and the 
labeling method (direct fluorescence, indirect antibody, etc.).  The data generated from 
current microarray technologies are comparable, especially when mining for genes that 




is important to be aware of the differences between probe annotations [9].  When 
integrating samples across experiments, it is important to keep a record of the platform 
assay used to analyze the samples [1].  The metadata in GEO has XML tags that contain 
platform information.  
Each sample in GEO has associated metadata that stores specific information 
about the samples, including how the samples were treated in the laboratory setting to 
generate biological outcomes. The associated metadata plays a crucial role in the 
integration of data across studies. GEO DataSets and Data Series contain metadata stored 
in parsable XML format. Specific XML tags that are relevant while integrating data 
across experiments are retrieved and stored in consistent representations.  However, the 
content within the XML tags are user defined and do not require users to follow 
consistent vocabulary. Drop down menus with standardize laboratory terms are not 
provided, causing increased variability in the content encompassed between XML tags.  
For example, the content of the XML tag, Title, requires users to define the treatment 
used on their samples in the laboratory experiment.  For Sample A, the user may define a 
control sample as “B305 immature DCs without IFN alpha treatment.”  For Sample B, 
the user may define a control sample as “iDC_6h.”  Simply parsing the content for the 
XML tag, Title, would not provide information that Sample A and Sample B are controls 
and that they contain a population of untreated cells.  Similar to the above examples, 
content between XML tags are stored using lengthy phrases that are not machine readable, 
making data integration an arduous task. 
Due to the inconsistencies described in this section, integrating across GEO 




DataSets, only 6% of the samples have been combined, creating a huge backlog. The 
methods in this dissertation show how combing previously overlooked samples can 
generate models that are supported by in silico analysis.  
 
Analysis Pipeline: Gene Pattern 
Gene Pattern is a web service tool that is hosted by the Broad Server. Gene 
Pattern can be used to analyze different types of genomic data including differential 
expression analysis on data generated from microarray experiments and NGS [10]. There 
are modules within Gene Pattern that interact with GEO in order to acquire samples from 
GDS and GSE experiments. The interaction between Gene Pattern and GEO makes data 
acquisition a simpler process. 
Once data are available in Gene Pattern, analysis pipeline can be created using the 
Pipeline Designer. The Gene Pattern Pipeline Designer allows users to create workflows 
that can start and finish analyses without breakpoints between each processing 
component. The different analysis modules in Gene Pattern can be connected to show the 
flow of data through the pipeline. The output from one module can serve as an input to 
the following module. The Pipeline Designer can be used to track analysis of each 
module and retrieve individual results when applicable [10]. The Pipeline Designer is 
useful when performing concurrent processing; however, to successfully integrate GEO 
experiments, samples must be annotated. A consistent way to annotate samples or 
represent metadata does not exist in Gene Pattern. The ontological representations used in 
this dissertation solve the missing annotation component in Gene Pattern. Through the 
use of ontologies, GEO samples can be annotated with the corresponding biological of 




Although Gene Pattern does not have a methodology to create standardized 
representations, there are several modules that aid in preprocessing and analyzing high 
throughput data. Samples from high throughput data can be classified or clustered using 
machine learning algorithms. Classification methods can be used to create a model, 
which can be used to predict and classify samples with unknown class variables. Similar 
to clustering methods in GEO, Gene Pattern has modules that perform clustering analysis 
by grouping genes that share similar expression patterns. The use of machine learning 
classification techniques can generate predictive models that may provide additional 
insight into experimentally generated data. Machine learning algorithms can be used to 
analyze various data sets and classify gene expression data based on different 
phenotypes.  
 
Data Analysis: Techniques and Tools 
 
Machine learning analysis to evaluate differential expression can be performed 
using tools such as Weka, R Statistical Package, and ML-Flex. Weka is software with an 
extensive collection of algorithms where analysis can be performed using classification 
and clustering methods. R is primarily a statistical tool that can be used to perform 
machine learning analysis and statistical tests. R can be used to create heatmaps, which is 
the standard way of visualizing results generated from differential expression analysis. 
ML-Flex is a tool that implements machine learning algorithms, independently and 











ML-Flex is an open source tool that is a wrapper to a suite of third party machine 
learning software, such as, Weka, Orange, R Statistical Software, and C5.0 Decision 
Trees [11-14]. Analysis in ML-Flex can be used to aid biomedical research by generating 
predictive models for biological and clinical data. Different classification techniques can 
be compared within a single ML-Flex experiment. ML-Flex allows computationally 
intensive algorithms to be performed in parallel. It is a command line tool written in the 
Java programming language that organizes machine learning analyses into an 
experiment-based framework.  In addition to analyzing data, ML-Flex keeps track of the 
various settings used in a particular experiment [15]. 
To run analysis in ML-Flex, an experiment file must be created.  This file must 
contain the following information in order to successfully analyze the data: location of 
input data, classification algorithm being used, and cross validation methods.  Other 
relevant fields can also be entered, such as feature selection variables, algorithms to 
perform feature selection, samples used for training and samples used in the validation set 
[15].  See Appendix A.  
 
Machine Learning Algorithms Used to Analyze High-Throughput Data 
 
A machine learning approach allows for the use of experiment driven analyses 
that may provide new insight on samples that may not be aggregated in GEO or other 
repositories.  Using machine learning methods can help separate genes that are 
differentially expressed.  Machine learning algorithms can help identify genes that have 
an increased level of gene expression, compared to genes that have a decreased level of 




Microarray results contain millions of probe IDs; therefore, the classification 
algorithms used need to be capable of handling a large number of features (i.e., probes).  
Classification algorithms help identify whether samples within a newly observed 
population belong to observations that have been previously made.  Three major 
classification algorithms used are discussed below.  
Naïve Bayes is a classification algorithm that relies on the assumption that each 
attribute is independent of the other and it helps estimate the conditional probabilities of 
predicted classes in a given experiment.  The performance goal of a Naïve Bayes 
classifier is to accurately predict the class of test instances in which the training instances 
contain class information.  One limitation of using Naïve Bayes is that it assumes 
independence between each attribute, which is not usually satisfied by the use of gene 
expression data.  Although the independence assumption is typically violated when 
analyzing gene expression data, the Naïve Bayes is robust if the rank order is maintained 
between classes [17]. Naïve Bayes is a simple classifier that has shown to perform well 
when combined with feature selection methods [17-19].      
The Decision Tree algorithm is a graph that uses a branching method to create a 
predictive model.  The goal of this learning method is to create a predictive model based 
on several input variables [12, 20].  Decision Tree chooses a feature that partitions the 
training data and then partitions the remaining data recursively until no further partitions 
can be made.  Finally, the tree is pruned to mitigate overfitting [12, 21]. 
Support Vector Machine (SVM) is a linear classification algorithm that separates 
two subsets of data with the largest margin by constructing a high dimensional boundary, 




such as genomic data used to analyze biological samples [19, 22]. SVM works well in 
dealing with large feature sets and is able to successfully identify outliers.  SVM is 
capable of using prior knowledge information in terms of training data to make 
distinctions between two different instances [23, 24].  
A significant problem with high throughput data are that the numbers of features 
(genes) greatly exceeds the number of instances (samples).  To manage this problem, 
feature selection can be used to reduce the number of features.  The ReliefF algorithm has 
been successfully used as a feature subset selection method [25, 26]. The algorithm does 
not assume independence between features and selects instances by giving more weight 
to features that can distinguish between classes.  This allows for the estimation of 
attributes according to how their values differentiate between samples that are close to 
each other [25].  The ReliefF algorithm is not limited to two class experiments and is able 
to handle noisy data.  The performing feature selection has successfully been applied to 
microarray data, leading to the selection of informative cancer genes [27].  
In a study performed by Wang et al. [27], feature selection methods were 
compared in three cancer related data sets: ALL/AML leukemia, MLL leukemia, and 
colon cancer.  Along with ReliefF three additional feature selection methods were used to 
compare the data sets: Information gain, Gain ratio, and X2 statistic.  Information gain is 
a type of feature selection that can be used to define a set of attributes that accurately 
build a predictive model.  Gain ratio is a modification of information gain and reduces its 
bias by taking the size of branches into account using a Decision Tree algorithm.  The X2 
statistic method evaluates each feature based on the X2 statistic of each feature compared 




better than other methods when analyzing the ALL/AML Leukemia data [27].  In another 
study performed by Kononenko et al. [28], ReliefF, along with other versions of Relief, 
were used to analyze artificial and primary tumor samples.  This study clearly showed 
that Relief-F was better at estimating attributes even if the data are noisy or incomplete 
[28].   
 
Ontologies 
GEO has a process of integrating samples into curated DataSets; however, there is 
a backlog of transforming original submissions into DataSets. Developing ontologies can 
aid the process of integrating related samples that have been overlooked by GEO. A 
consistent standard using ontologies can not only help data integration but also help 
perform analysis on the newly curated data sets. The ontologies developed for this 
dissertation were used to organize multiple GSE experiments from GEO into novel 
experiments that can be analyzed in silico. Using ontological components, various 
attributes of an experiment, such as, platform information, sample IDs, clinical or 
biological relevance are represented.  
Ontologies are a standardized way of representing knowledge in a particular 
domain. They are composed of consistent representations that can be used to structurally 
organize various entities extracted from the metadata.  Ontologies can be shared with 
other researchers to improve the consistency of knowledge in a given domain [4, 29].  
Storing metadata from GEO as an ontological entity makes the information associated 
with each GEO experiment computationally tractable.  Repositories, like GEO, provide 
metadata information regarding biological experiments; however, specialized knowledge 




resolve the complexity of data integration, ontologies can be developed to store metadata 
information that describe experimental properties of GEO Series records as ontology 
components that are machine readable.  Once the knowledge domain is organized in 
relationship to classes and properties, logical reasoning can be performed upon the 
representations.  
Ontologies are used in the field of biomedical informatics to solve different 
problems such as: unifying vocabulary across knowledge domains, consolidating and 
supporting common data formats, creating inferences on asserted ontologies, and driving 
natural language processing [4, 29, 30].  Ontologies can be created as reference 
ontologies and as application ontologies.  Reference ontologies focus on theoretical 
knowledge that demonstrate a larger knowledge domain, whereas application ontologies 
focus on a smaller knowledge domain and solving a specific problem using the smaller 
knowledge representation.  Reference ontologies such as the Gene Ontology (GO) and 
the Foundational Model of Anatomy (FMA) have unified the language surrounding their 
respective domain [31, 32].  They have defined the terms and relationships between terms 
and provide a hierarchical basis for annotation of data.  Application ontologies can often 
use portions of a reference to represent a knowledge domain [30].  For instance, the 
Experimental Factor Ontology (EFO) supports the analysis and data handling of various 
experimental variables stored in EBI (European Bioinformatics Institute) databases [4]. 
In this dissertation, application ontologies are built to provide a structured way of relating 







Ontologies can be created using a Graphical User Interface (GUI), such as, 
Protégé, OBO (Open Biomedical Ontologies)-edit, etc. [33-35].  A GUI allows users to 
create ontologies using visual descriptors versus a text-based interface.  Protégé has an 
intuitive GUI that allows the users to edit and develop ontologies.  The ontology files can 
be imported and exported in various formats: Web Ontology Language (OWL), 
Extensible Markup Language (XML), and Resource Description Framework (RDF) [33].  
Another GUI tool commonly used to create ontologies is OBO-Edit.  The ontologies 
created using OBO-Edit contain the OBO format that is composed of stanzas describing 
the various entities of an ontology [35, 36].  The ontologies in this dissertation are created 
in OWL, which can easily be parsed using the Java programming language.   
To successfully build ontologies using GEO experiments, the metadata for each 
GEO experiment needs to be parsed, extracting the content from specific XML tags. 
Using the extracted content, a base ontology is created using four ontological 
components: classes, individuals, object properties, and annotation properties. Next, 
relationships between appropriate entities are constructed using is-a relationships and 
user defined object properties.  The use of annotation properties helps store the 
descriptive entry related to how each sample is treated in the laboratory.  Logical 
definitions may be added to the components in order to accurately define the knowledge 
space within the ontology. Building the base ontology helps reduce the amount of 
implicit information. A reasoner is a complex algorithm used in ontologies to generate 
logical consequences from a set of asserted terms in the base ontology [37].  HermiT is 




relationships between OWL entities, and to classify various OWL classes [38].  The 
detail on how the ontologies are created is described in Chapter 5, (OBDI, A Novel 
Pipeline). 
 
Incorporating Prior Knowledge Information 
 
When analyzing biological data, applying prior knowledge information about a 
biological domain plays a crucial role in assessing a newly developed predictive model.  
To decipher complex biological systems, it is important to incorporate the diverse data 
types along with preexisting knowledge of well-understood biological systems [39].  
Selecting features based on domain specific, prior knowledge can have a positive effect 
on the performance of a model.  When analyzing high dimensional data, such as 
microarray, incorporating prior knowledge can positively affect the performance of the 
machine learning algorithms [40].  
Domain specific prior knowledge information helps evaluate the machine learning 
results in order to determine biological meaning [39].  It has already been established that 
feature selection is an important method to reduce the number of probe IDs to a 
manageable group.  In order to assess domain specific knowledge, further investigation 
must be performed on the features selected using machine learning analysis [40].  
Research performed at the bench often requires preexisting knowledge in order to make 
inferences about the current investigation [41].   
 
Clustering Genes via Known Biological Pathways 
 
Several approaches can be used that cluster genes into biological relevant sets 




and Database for Annotation, Visualization and Integrated Discovery (DAVID) [42]. The 
KEGG database contains extensive information about biological pathways [43].  The 
biological pathways in KEGG represent a network of knowledge that contains 
biomolecular interactions.  KEGG can be used to query specific genes, and explore how 
these genes play a role in specific biological pathways.  The KEGG database contains the 
most comprehensive information about biological pathways across different species [43].  
The PANTHER classification system also consists of a large number of pathways that 
can be used to cluster a set of features (genes or probe IDs).  The advantage of using 
PANTHER is that genes can be passed in a batch file and PANTHER associates the 
genes to corresponding pathways.  PANTHER also supports various ID formats, which 
allows the application of a wide range of high throughput analyses [42]. DAVID 
bioinformatics consists of a collection of analytical tools and biological knowledge base 
targeted at extracting information from large lists, including genes, proteins, and probe 
ids. DAVID also had visualization capabilities that help visualize genes on KEGG 
pathway maps [44].  
Biological relevance can be examined using other methodologies that do not 
involve the interaction of biomolecular components.  GoMiner is a tool that uses GO to 
identify meaningful biological information in genomic data.  GoMiner supports 
classification of genes according to biological process, cellular components, and 
molecular functions.  When assessing microarray data with GoMiner, the user can 
determine whether specific genes are upregulated or downregulated.  GoMiner also links 





Incorporation Prior Knowledge Using Ontologies 
With the use of ontologies, biological or clinical knowledge can be communicated 
among researchers working in the same domain knowledge.  Ontologies help share newly 
discovered knowledge within a research community[41].  Preexisting ontologies can be 
used to build larger ontologies, thereby extending the domain knowledge of the original 
ontology.  Furthermore, biological data stored in databases require the incorporation of 
additional domain specific knowledge that may be required for analysis and interpretation 
of the data [41].  In the field of biomedical research, the cell ontology is commonly used 
to incorporate a structured vocabulary of various cell types.  The plant, animal, fugal, and 
prokaryotic kingdoms are included in this ontology.  The cell ontology also includes cells 
in their native state and those that are experimentally modified.  Within the ontologies 
created in this study, the cell ontology is extended to support the different in vitro cell 
types that are retrieved from the metadata of specific GEO experiments.  The structured 
vocabulary of cell types, along with newly added information, helps facilitate the 
interoperability among databases that house high throughput data [46, 47]. 
The tools described above can be used to successfully incorporate domain specific 
prior knowledge; thus, checking for biological relevance in the machine learning results. 
By incorporating domain specific knowledge, meaningful models for bench researchers 






















Figure 3.1: The bar graph depicts the number of samples that are being added 
quarterly from 2001 through 2013. The pie chart shows the number of samples 
that are curated into GEO DataSets. 
  
 
4. OVERVIEW OF CANCER IMMUNOTHERAPY 
Cancer immunotherapy is a treatment method that harnesses a patient’s immune 
system cells to treat malignancies.  The primary goal of cancer immunotherapy is to 
stimulate the patient’s immune system response in order to fight tumor cells. 
Immunotherapy vaccines can either work by boosting the general immune system 
response or by training the immune system to attack specific cancer cells [48].  The field 
of immunology contains several cell types and pathways that interact to generate an 
effective immune system response. To focus on a single problem in the field, an ontology 
driven approach is used to represent the domain knowledge and expand upon the cell 
ontology.  The ontology driven approach also allows for the communication of 
knowledge amongst researchers [41], allowing for the development of cancer 
immunotherapeutics.  Currently, the success of cancer immunotherapy is as an adjuvant 
to other cancer therapeutics.  Certain chemotherapeutics appear to enhance the effect of 
cancer vaccines, by increasing the T cell mediating response against tumors [49].  
Immunotherapy treatments are designed to empower the patient’s immune system, 
creating a prolonged antitumor response.  Although efficacy of immunotherapy vaccines 
has improved, there remain challenges in developing successful clinical assays to monitor 
immune responses in patients [50].  Cancer immunotherapy is an active field of research; 




Among the various immunotherapy methods, Dendritic Cell (DC) vaccines are a 
newly emerging form of cancer vaccines.  DC vaccines are meant to harness the body’s 
immune system response in order to fight tumor cells by initiating a CD8+ antitumor T 
cell response [51].  Due to the recent advancements in cancer therapeutics, DC based 
vaccines have shown promising results for initiating an antitumor immune response in 
melanoma, prostate cancer, glioblastoma, and non-Hodgkin lymphoma [51-53].  DCs are 
immune system cells that play a role in recognizing, processing and presenting antigens 
to T cells.  To create a DC-based cancer therapy, monocytes are harvested from a patient 
and stimulated in the laboratory to produce DCs that phagocytose the patient’s tumor in 
vitro.  The DCs are injected back into the patient where they generate a strong antitumor 
immune response [51]. 
Although DC vaccines have shown promising results when used with other cancer 
treatments, there are certain roadblocks that may cause DC vaccines to become 
ineffective.  DCs are the most potent Antigen Presenting Cells (APCs); however, to 
successfully initiate an antitumor T cell response DCs must be in their mature state. 
APCs efficiently process antigens using phagocytosis or endocytosis.  Once the antigen is 
processed, Major Histocompatibility Complex (MHC) class proteins and the processed 
antigen are displayed on the APC surface.  Additional cell surface molecules, called 
Cluster of Differentiation (CD), CD80, CD83, or CD86, are also present on the APC 
surface. The surface markers CD80 and CD86 are part of the B7 family of membrane 
surface markers.  The presentation of these surface markers allows APCs to effectively 
interact with T cells [54, 55]. Figure 4.1 is a simple adaptation of the interaction of DCs 




a mature DC interact with T cell surface marker to initiate a T Cell response [55].  
In immunotherapy vaccines, mature DCs have been shown to prime and boost the 
antigen-specific T cell response in cancer patients.  There are several treatments that can 
be added to successfully mature DCs; however, research in this field has shown that 
maturation of DCs also induces regulatory T cells (Tregs).  When induced, Tregs have 
been shown to suppress the activities of effector T cells and DCs.  The ability to produce 
an effective antitumor response is the goal of cancer immunotherapy; unfortunately the 
induction of Tregs renders the treatment ineffective [53, 56, 57]. 
DC vaccines offer an effective and potentially nontoxic treatment option for 
cancer patients.  DC vaccines have proven to be effective in clinical trials and they have 
been successfully used with other cancer therapies [51, 53].  To explore the data in this 
growing field of research, an ontology driven approach can be used.  This approach will 
allow researchers to annotate data, expand on the existing domain knowledge, and share 














Figure 4.1: The immunotherapy vaccine is generated ex vivo, in the presence of 
tumor antigen loaded DCs and maturation stimuli (IFNα). The DCs uptake 
tumor antigens and present it to CD8+ T cells coupled with MHC I. This leads 
to the proliferation of CD8+ T cells and the initiation of a T cell mediated 




5. OBDI, A NOVEL PIPELINE 
  The OBDI pipeline incorporates various processes that are required to prepare 
integrated experiments that can be analyzed in silico. OBDI pipeline integrates 
informatics tools that are used independently in the field (see Figure 5.1).  The ability to 
use these tools in a single pipeline allows users to integrate samples that were 
overlooked by previous curation efforts.  OBDI was developed to support the reuse of 
data by annotating both GSD and GSE experiments from GEO experiments such that 
novel combinations of experiments can be analyzed using the pipeline. In Figure 5.1 the 
five components of OBDI are depicted. A general overview of each component is 
provided.   
The OBDI pipeline is written in the Java programming language and it contains 
five components: 1) Build Ontology, 2) Acquire Data, 3) Organize Data, 4) Process 
Data, and 5) Analyze Data.  
To execute each experiment in OBDI a configuration file is required.  Since data 
integration and analysis is a multistep process, a configuration file allows users to track 
the input of different parameters that are required to successfully execute OBDI.  The 
configuration file can be created in any text editor.  The various parameters of the 
configuration file are provided in Appendix B. 
The first component, Build Ontology, requires users to build the base ontology.  




GEO samples that will be integrated to create novel experiments.  Once the base 
ontology is built, the next four components (i.e., Acquire Data, Organize Data, Process 
Data, and Analyze Data) are executed consecutively within OBDI.  In the second 
component, Acquire Data, data are directly acquired from GEO by providing the http or 
ftp link for the data associated to each GEO DataSet sample.  There is no limit on the 
number of GEO data that can be acquired.  The third component, Organize Data, 
requires the organization of a single experiment from annotated data downloaded during 
the Acquire Data step.  Currently, OBDI, supports Affymetrix Microarray Chips, 
Illumina Bead Chip, and RNA-Sequencing (RNA-Seq) experiments.  More platforms 
can reasonably be integrated according to the user’s requirements.  The obtained 
samples are organized by reasoning over the base ontology that was created by the 
Build Ontology step.  The reasoned ontology creates a directory structure and a 
mapping file for the annotated machine learning experiments.  The directory contains 
subfolders that are associated to the specific machine learning conditions.  The mapping 
file associates each sample to the specific machine learning condition, allowing the 
samples to be stored in their appropriate directory.  The Process Data step requires 
preprocessing of the annotated experiments. The appropriate modules, from Gene 
Pattern, required for each gene expression platform is implemented in the Process Data 
component of OBDI.  During the last step, Analyze Data, the normalized data are 
analyzed using ML-Flex.  The output from this analysis allows users to interpret the 
results for biomedical purposes. 
OBDI is a command line pipeline that must contain the following input 




Module (Affymetrix, Illumina, RNA-Seq), and the Configuration File.  The Build 
Ontology component can be executed separately. This is recommended because 
individual GEO Series record samples and metadata information is automatically 
inserted into the base ontology.  In following sections, the OBDI pipeline components 




In the Build Ontology step of the OBDI pipeline, the following steps are 
required: building base ontology components, creating an indexing file using the 
HermiT reasoner, and automatically creating a local directory structure that stores the 
annotated machine learning experiments.  
 
Building Base Components of the OWL File 
 
Ontologies in this dissertation are developed using the OWL syntax.  Different 
fields of each GEO experiment are described using the following owl components: 
classes, individuals, and properties.  Classes represent the main building blocks in an 
OWL ontology, and classes can include OWL individuals as instances [33].  There are 
three classes created to represent the components from a GEO experiment: condition, 
sample, and treatment.  A fourth class, cell, is imported from the cell ontology [46, 47].  
Treatment contains information about the different stimuli that were used to treat 
biological samples in a GEO experiment.  A treatment may have two of more 
subclasses that refer to control and experimental stimuli.  The imported cell class 
contains a subclass, cell in vitro, to store cells or other specimens that are manipulated 




components, object properties are used.  The object properties along with the domain 
and the range are defined in Table 5.1. 
 
Creating A Directory Structure in the User’s Local Drive 
 
Ontologies developed using the OWL syntax can be parsed by implementing 
libraries available in the Java programming language [58].  I used the OWL Application 
Programming Interface (API) to reason over the base ontology.  By using the HermiT, 
reasoner within the OBDI pipeline, classes that did not satisfy the user-defined 
condition in the base ontology are printed to the console.  This allows the user to check 
for any inconsistencies that may occur between the OWL entities.  Once the ontology is 
reasoned without inconsistencies, the user can access the inferred OWL entities [59].  
Using the reasoned OWL file, a directory structure mimicking the ML-
Experiment OWL class can be created.  Each directory structure contains the name of 
the machine learning experiment with subfolders that contain the conditions associated 
with that experiment.  To build the directory structure, a single OWL class is parsed.  
The OWL class ML-Experiment and all it subclasses are parsed out to create the 
directory structure.  The subclasses for each ML-Experiment are represented by the 
machine learning condition associated to the specific ML-Experiment.  An example of 
how each ontology is used to create the file structure in the user’s local system, 
depicting the integrated samples is discussed in each experiment chapter. 
 
Creating an Indexing File Using the Reasoned Ontology 
 
GEO provides metadata files that store experiment information in a structured 




experiment does not exist.  This makes it difficult to organize samples in a logical and 
meaningful manner.  Ontologies were developed to simplify the complexity of data 
integration across GEO experiments.  
The development of ontologies provides a means of integrating samples across 
GEO experiments. The key to organizing the samples is based on the ontology 
developed to annotate across related GEO experiments. Creating the directory structure 
and generating the master-indexing file occur in the same Java module.  An indexing 
file is created using the reasoned OWL file.  An indexing file allows users to place raw 
samples from GEO experiments into an appropriate ML-Experiment subfolder, which is 
represented by the appropriate machine learning condition (See Appendix C for details).   
 
Acquire Data 
The methods needed to acquire data from the GEO repository are similar.  Each 
GEO experiment entry contains a link to download the samples from that experiment.  
The user must specify this link in the OBDI configuration file.  The downloaded data 
are stored temporarily in the output directory.  As the samples are acquired from GEO, 
the metadata files are also downloaded and processed with the pipeline. 
 
Extracting Metadata 
The process to extract metadata information from GEO data is similar across 
experiments.  Each samples in GEO has an XML file [7] that contains the associated 
metadata. The metadata file for each experiment contains several fields that guide the 
development of various OWL entities.  The XML tag retrieval was written in native 




navigation through the tree structure of XML documents.  By using path expressions, 
XPath can be used to select specific nodes from XML files.   
The following XML fields are retrieved for developing the ontology: Sample iid, 
the Title field for the sample, Platform iid, and the Title field for the particular platform. 
To maintain clarity in the document, the Title fields will be referred to as Sample Title 
and Platform Title.  The Sample iid is an alphanumeric identification assigned to each 
sample in an experiment.  A single sample in GEO is comprised expression values or 
sequencing data for a given set of genes.  Each Sample iid is associated to a Platform iid 
and a Sample Title.  The Platform iid is also an alphanumeric identification that is 
associated to the Platform Title, which provides information about the specific high 
throughput technique used to analyze the sample. The Sample Title provides 
information about how a particular sample was treated in the laboratory before 
performing the high throughput analysis.  The retrieval of these XML tags serves as a 
key component in building the base ontology. 
 
Organize Data 
The OBDI pipeline requires that data modules are developed for each type of 
data platform.  High throughput analysis techniques measure different biological 
samples at varied coverage [61].  Due to the variability in biological data formats, the 
preprocessing for each platform is handled independently in OBDI.  The samples used 
in this have been analyzed on three different platforms: microarray experiments 
performed using Affymetrix, differential expression analysis or RNA-Seq samples, and 




For the GEO experiments analyzed on Affymetrix the raw data are downloaded 
in tar format.  The first step to reveal the raw data is to extract the tar file.  Individual 
samples in the experiment are compressed; hence, each sample file is unzipped to reveal 
the raw data.  The intensity files in Affymetrix experiments are stored as cel files.  
Although the downstream processing of RNA-Seq data are different from expression 
array data, similar preprocessing method is used to extract raw data files. The RNA-Seq 
samples processed in OBDI were sequenced using the Illumina Genome Analyzer.  
Data for each sample are stored as Sequence Alignment Map (SAM) or a Binary 
Alignment Map (BAM) file.  A SAM file is tab-delimited data that contain aligned 
sequences. Each SAM file has 11 mandatory fields that appear in the same order. The 
BAM format is the machine readable version that stores the data in binary form [62].  
The Illumina Expression Beadchip data are acquired using Gene Pattern.  Once the data 
are available locally, each sample is separated as a column and stored as an individual 
file.  In all three modules, the samples are organized using the ontology and the 
metadata XML file.  
When generating the ontology, the platform information from each metadata file 
is extracted.  Within the XML metadata file, the platform information is associated to 
each sample in the GEO Series record.  In most cases, this information is specified in 
the Platform Title of the XML file.  This is information is added to the ontology as an 
annotation property to the respective sample.  This provides users the ability to 
distinguish between platforms within the base ontology.  Once a single platform is 
chosen, it is added to the name of the curated experiment.  Samples that are not part of 




method is generalized due to the ontology; however, it is a key component because the 
preprocessing methods vary among platforms and data types.  
When combing data across GEO experiments there are several samples; 
therefore, the reasoner is used to add samples to the appropriate condition.  Using the 
asserted ontology and the inferred links that are established by the reasoner, researchers 
can create similar machine learning experiments using other GEO experiments.  When 
the reasoner is applied, the sample individuals denoted with a GSM ID are inferred as 
members of the appropriate condition.  Based on the equivalency classes defined in 
each ML-Experiment subclass, the GSM IDs are inferred into the specific machine 
learning experiment.  This allows users to build in silico experiments outside of GEO. 
 
Process Data 
Once the samples are organized into a structured directory system, the samples 
can be used to perform machine learning analysis.  However, before performing meta-
analysis, the integrated data sets must be normalized and processed into the appropriate 
file format.  The goal of this project is to not only integrate GEO experiments, but also 
integrate bioinformatics tools into a single pipeline. To perform some of the 
preprocessing analysis, Gene Pattern is used [10].  
For Affymetrix expression data, the Robust Multi-array Average (RMA) 
normalization technique is considered the standard [63].  When analyzing Illumina 
Expression Beadchip data from GEO, samples are already normalized using quantile 
normalization [63].  Gene Pattern generates a tab-delimited file for all three modules.  
This generalized file format can be converted to the Attribute-Relation File Format 




In order to use the OBDI pipeline in conjunction with Gene Pattern, users need 
to create an account with a Gene Pattern username and password.  This is a simple two-
minute process that provides each user with an account that allows them to access Gene 
Pattern modules and all the analysis performed on the Gene Pattern server.  The 
username and password are passed into the OBDI configuration file so that users are not 
interrupted by prompts for this information (See Appendix D).  Gene Pattern modules 




The final step involves analyzing the data from the annotated experiment using 
ML-Flex.  The commonly used fields in the ML-Flex experiment file are defined in all 
the ontologies as annotation properties.  Reasoning over the base ontology generates the 
experiment files required to execute the analysis in ML-Flex.  Until this point, the 
ontologies were accessed using the OWL API [59]; however, for this step XPath is used 
to write a generalized method that creates ML-Flex experiment files for each machine 
learning experiment.  The annotation properties are organized under a different XML 
namespace, which allows for easy parsing using XPath.  A user can define XML 
namespaces user to avoid conflict between elements, while mixing different documents.  
Although the annotation properties are defined in the same ontology, it is important to 
keep the ML-Flex experiment file fields in a different namespace because they address 
a different step in the pipeline.  The namespace assigned to the annotation properties is: 
http://bmi.utah.edu/ML-Flex. This allows for easy and error free extraction of the 




When more than one algorithm is used, ML-Flex performs ensemble-learning 
[15, 64].  When only one algorithm is specified, the ensemble-learning method will not 
be performed [64].  This unique feature of ML-flex is used to compare across different 
algorithms.  There are seven ensemble-learning methods implemented in ML-Flex:   
1. Majority Vote tallies the number of times a data instance was predicted 
for a class and favors the class that receives the most counts.  If multiple 
classes receive the same vote, majority vote will choose a class at 
random.  
2. Weighted Vote emphasizes single predictions that are considered the 
most informative and places higher emphasis on those individual 
predictions that perform the best. 
3. Select Best makes a prediction based on the individual prediction that 
received the best Area Under the Curve (AUC) in nested cross validation.  
4. Max Probability examines the probability for each class across 
individual predictions, and the class with the highest individual 
probability is selected.  
5. Mean Probability examines the probabilities for each class across 
individual predictions and the class with the highest average probability 
is selected.  
6. Weighted Mean Probability is a combination of the Weighted Vote 
method and the Mean Probability method. Predictions are calculated 
similar to the Mean Probability method but weight is assigned to each 




7. Finally the Stacked method uses the probabilities from individual 
predictions and trains a second-level classification algorithm to make 
cumulative predictions based on those values. The Decision Trees 
algorithm is set as default for the second-level predictions.  
After the analysis is complete, an output folder for each experiment is created.   
This folder contains a summary of results, which can be viewed on a browser.  
These results can also be parsed in the output directory.  When comparing different 
classifiers in ML-Flex, results are aggregated into a single table, which makes it easy to 
compare the analysis among different algorithms.  Statistical measures, such as AUC, 
accuracy, error rate, and recall is also summarized in a table.  The advantage of using 
ML-Flex is that the postanalysis results are summarized allowing the user to evaluate 
the performance of the classification algorithms.  Users can further process the machine 












Table 5.1: There are six object properties that are used to relate OWL entities. It is 
optional to specify domain and range restrictions to an object property. Domain and 
range allow users to specific what entities should and should not be related. Defining a 












Object Property Domain Range 
containsCellType   
hasCondition sample condition 
hasSample ML-Experiment sample 
hasTreatment sample treatment 
inExperiment condition ML-Experiment 
isTreatmentOf   
Figure 5.1: This figure shows the generalized diagram of the OBDI pipeline. It 




6. PIPELINE USE-CASES: CANCER IMMUNOTHERAPY         
EXPERIMENTS 
 
Cell ontologies contain extensive information about cell types in their native state.  In 
the OBDI pipeline, the biological knowledge in the cell ontology is extended by adding 
information about cell lines cultured in a laboratory setting.  To successfully integrate 
data across GEO Series records, it was important to incorporate prior knowledge 
information in relation to various cell types.  Incorporating the cell ontology supports 
expanding the OBDI framework to other biomedical domains.  The information within 
the cell ontology can be extended to include in vitro cell types that are cultured in the lab 
for gene expression and RNA-Seq analysis.  
The OBDI pipeline helps generate hypotheses and also informs existing 
hypotheses by adding new information that is generated from analyzing newly curated 
experiments. To analyze cancer immunotherapy as a use-case with the OBDI pipeline, 
four use-case experiments are evaluated by performing meta-analysis. Each experiment is 
curated using ontological representations. Experiment 1 consists of information about 
DCs and treatments related to maturing DCs. This experiment served as a staring point to 
explore the cancer immunotherapy space.  Since the downstream activation of T cells and 
the induction of Tregs depend on the maturation of DCs, it was important to characterize 
these cells, in silico, successfully. Based on the results from Experiment 1, the 




Experiment 2 explores how various T cell subtypes are classified. The ontological 
representation for Experiment 2 deals with treatments that lead to T cells differentiating 
into different subtypes. Biomolecular components relevant to T cells are explored to see 
if new information from analyzing Experiment 2 can help enhance the results in 
Experiment 1. To complete the model exploring a tumor microenvironment, it is 
important to analyze differentially expression in a specific cancer cell lines. In 
Experiment 3, samples were consolidated so that IFNα, a specific treatment used to 
mature DCs, is also used to evaluate gene expression in cancer cell lines. Finally, in 
Experiment 4 OBDI is extended to include other sequencing data making OBDI inclusive 
of other data types. By relating a specific treatment to DCs and to a clinical therapy 




7. EXPERIMENT 1: CHARACTERIZATION OF DENDRITIC                         
CELL MATURATION 
 
To validate the OBDI pipeline, the field of cancer immunotherapy is explored 
because of the complexity of the data set and the potential benefits from combining data 
across experiments. Since there are several methodologies used to generate cancer 
immunotherapy treatments, I focus on acquiring data that allow the exploration of the 
immune system response in DC based vaccines. For an overview of topics related to 
cancer immunotherapy see the chapter titled, Overview of Cancer Immunotherapy. 
Mature DCs are the most effective Antigen Presenting Cells (APCs) for initiating 
a T cell mediated immune response.  Normally DC cells are in an immature state in the 
mucosal membranes or the epithelial layer of the skin, but when DCs capture pathogenic 
or inflammatory stimuli, they mature, migrate to the lymph nodes and present antigens to 
T cells [65].   There are surface markers that have upregulated expression on mature DCs.  
The GEO samples in Experiment 1 assessed maturity based on three Cluster of 
Differentiation (CD) markers: CD 80, CD 83, and CD 86, all of which are standard 
markers used in the field of immunology to assess mature DCs [65]. Figure 7.1 displays 
how a DC can be matured and how a mature DC interacts with CD8+ T cells to initiate a 
immune system response.  
The weakness of DC vaccines is an ineffective antitumor immune response 




tumor antigen being presented by the mature DCs.  This tolerance to tumor antigen is an 
unwanted effect that causes immunotherapy vaccines to become ineffective [51, 57]. 
Induced Tregs act as a barrier to prevent the effector functions required to kill 
tumor cells [56, 57].  There are several known mechanisms by which DCs induce Tregs.  
In recent studies, researchers have shown indoleamine 2,3-dioxygenase (INDO) is one 
mechanism responsible for induction of forkhead box P3 (FoxP3)+ Tregs. FoxP3+ 
induced Tregs are generated by DCs and this induction is caused by multiple factors 
including INDO, retinoic acid, Vitamin D, and Transforming Growth Factor-beta (TGF-
β).  
Experiment 1 uses the OBDI pipeline to combine data from four GEO 
experiments that are publically available.  The objective of Experiment 1 is to 
successfully characterize the maturation of DCs across the 11 treatments that occur across 
the four GEO studies.  Since the four GEO Series records used in Experiment 1 have not 
been curated by GEO, a secondary analysis of these GEO samples may provide important 





The ontology is built around experiments measuring the maturation of DCs.  
Peripheral Blood Mononuclear Cell PBMC is added as a subclass to cell in vitro.  Using 
the OWL classes, treatment and cell in vitro, machine learning conditions are established.  
These conditions play a role in classifying individual instances (samples) during the 




with is-a relationships.  The next several steps describe the detailed framework of how 
the base ontology for Experiment 1 is created: 
1. The cell ontology is imported into the OWL file created for Experiment 1.   
2. Within the cell ontology there are two OWL classes, cell and cellular_component. 
Under cell, two subclasses differentiate between native cell and cells generated in 
vitro [46, 66].  
3. The OWL class PBMC is added as a subclass to cell in vitro.  PMBCs are 
obtained from blood banks for experimental purposes.  They are inclusive of 
different types of immune system cells.  Since this experiment deals with DCs, 
MDDC (Monocyte Derived Dendritic Cells) is added as a subclass to PMBC.  
Various DC subtypes are added based on surface marker expression to 
differentiate between mature and immature subtypes [66].  The subtypes are 
disjointed from each other. 
4. The next three OWL classes are unique to the ontologies generated in OBDI: 
treatment, condition, and sample.  
5. The treatment contains a subtype DCTreatment.  The two types of DC treatments 
used in this experiment are control treatments and maturation treatments.  These 
subclasses have individuals associated to them as OWL members.  The members 
of the ControlTreatment subclass are: untreated and isotype.  The members of the 
MaturationTreatment subclass are: Poly (I: C), anti-FcgRIIb, CD40L, galectin, 





6. The subclasses defined under the condition OWL class for Experiment 1 are 
mature and immature.  The two conditions are disjointed from each other.  The 
equivalency for each condition is established by adding the appropriate cell type 
and treatment subclasses that would come together to establish the machine 
learning condition OWL class.  Object properties, containsCellType and 
hasTreatment are used to associate the cell type and the treatment, respectively.     
7.  Sample is the final class that completes the base ontology.  The machine learning 
experiment, ML-Experiment, is a subclass of sample.  Experiment 1 annotated 
from this ontology is a subclass of ML-Experiment.  DCMaturationU133Plus 
contains equivalency classes associated by the mature or immature OWL entities.  
8. The final step is automated by implementing the OWL API [59] into the pipeline.  
In this step all samples from the GEO Series records are added as OWL 
individuals and associated to sample as members.  The Sample iids that are parsed 
out of the metadata XML file are added as an instance to the sample OWL class.  
There are different annotation fields that can be added to individuals.  The Sample 
Title parsed out of the metadata file is added as a RDF comment under 
Annotation Properties to each corresponding Sample iid individual.  The 
information from the Title Text field is summarized into a treatment term and 
stored as an individual.  Each sample member is associated to a particular cell 
type by the containsCellType object properties.  Finally, hasTreatment object 
properties are used to link the sample members to the treatment members. 
The above-defined logic forms the framework of the base ontologies used in the 







I consolidate 50 samples from the following four GEO experiments: Fulcher et 
al., Dohnal et al., Ebstein et al., and Dhodapkar et al (see Figure 7.3).  Across the four 
experiments, the researchers generated Monocyte Derived Dendritic Cells (MDDCs) by 
using a cocktail of GM-CSF and IL4.  Fulcher et al. identify expression differences 
between Galectin-treated DCs and LPS-treated DCs compared with untreated DCs.  
Dohnal et al. examine differential gene expression of a specific set of genes when LPS in 
the presence of IFNγ triggers DC maturation.  Ebstein et al. focused their study on a set 
of 1200 ubiquitin-proteasome system (UPS)-related genes, and found differences in UPS 
gene regulation between DCs matured with infectious stimuli (LPS and Poly(I:C)) versus 
DCs matured under T cell stimulatory or inflammatory conditions. The analyses 
performed by Dhodapkar et al. compared anti-FcγRIIB, inflammatory cytokines, or IFNα 
versus untreated and Isotype control [52, 67-69]. 
 
Organize Data 
The four GEO Series records were analyzed on the Affymetrix U133 2.0 Plus 
microarray platform.  The data organization method using the ontology is already 
described in the “Organize Data” section of the general methods used in the OBDI 
pipeline.  Once the four GEO experiments were downloaded into a temporary location, 
the first step involved extracting the tar file.  The samples were compressed in gzip file 




Figure 7.4 shows an example of how the DCMaturationU133Plus experiment looks when 
the directory structure is automatically created in the user’s local drive. 
The ontology serves severs as the core component to integrate samples across 
GEO experiments and to organize novel machine learning experiments on a user’s home 
directory.  This is a powerful and efficient way to integrating GEO Series records and to 
store the samples in an organized directory structure. 
Figure 7.5 shows the four GEO experiments from where the samples are acquired.  
The curated experiment using the OBDI pipeline contains 50 samples. The 50-sample 
data set was divided into a training (n=12) and a hold-out testing set (n=38). The training 
included all LPS [3] (n=6) samples and one to two randomly selected untreated [1] 
samples from each GEO experiment (n=6). Thus, the 12 sample training data contained a 
set of 6 control samples and 6 samples of DCs matured with LPS. The remaining 38 
samples are used as hold-out samples.  
 
Process Data 
For microarray data analyzed in Affymetrix, RMA method is used to normalize 
the data across the combined samples in each machine learning experiment [63]. RMA 
normalization contains the following steps: background adjustment, quintile adjustment, 
and finally a summarization step [63].  The raw Affymetrix cel files are zipped and 
normalized using the ExpressionFileCreator module on the Gene Pattern server [10].  
When normalizing Affymetrix data, a Gene Pattern clm annotation file is required.  This 
annotated file allows for accurate replacement of GSM IDs with the appropriate machine 
learning condition associated to that sample in the ontology.  The Gene pattern clm file 




however, the spacing is tab-delimited.  Each Gene Pattern clm file contains three 
columns: GSM ID, user defined machine learning condition, and the Title Text 
annotation for each GSM ID.  Using the clm file, the integrated GEO samples can be 
normalized [10, 63].  
The normalized data produced by the Gene Pattern module, 
ExpressionFileCreator, is stored as a tab-delimited file called a Gene Pattern gct file.  
This is the standard file format used by Gene Pattern where samples are represented in 
columns and the probe IDs are represented as rows.  The final file formatting happens 
outside the Gene Pattern server, where the tab-delimited file is converted to Attribute-
Relation File Format (ARFF) format for machine learning analysis.  
A generalized Java method is written within the pipeline to convert the 
normalized file generated by Gene Pattern into ARFF, which is used when running 
machine learning analysis in Weka [11].  Although Weka is not directly used in the 
pipeline, ML-Flex implements various algorithms that are used in Weka.  In an ARFF 
file, all the attributes (probe IDs or gene names) are listed in the beginning.  Next, the 
corresponding data value is listed for each attribute in a single line. At the end of each 
line, the machine learning class variable is listed [11]. 
 
Analyze Data 
Microarray data contain an extensive number of features; however, each feature is 
not relevant to the study of immunology.  The ReliefF ranking method is used on the 
training set (n=12) to select and rank features that successfully differentiate among 
classes [18, 27, 70]. The features are selected by adding top ranked features and stopping 




The Naïve Bayes classifier, a machine learning algorithm in ML-Flex, is used to 
characterize the maturation of DCs. The classifier is trained using the training set. The 
Naïve Bayes classifier uses all selected attributes and treats them as independent of one 
another. Leave One Out Cross Validation (LOOCV) is used on the training set to get an 
estimate of the generalized error.  
 
Results 
Generating Inferred Ontology 
Once the base entities are added to the OWL file, the HermiT 1.3.6 reasoner in 
Protégé is used.  The framework of the ontology provides a structured way of storing 
GEO related elements and the user-interpreted machine learning conditions.  Using the 
base ontology, I have successfully created a way to store metadata across GEO 
experiments in machine readable format. The next step is to add GEO samples to suitable 
conditions and, hereby, adding those samples to the ML-Experiment that contains the 
specific conditions as an equivalent class.  
To build new ML-Experiments users can manipulate equivalency classes 
associated by condition.  The OBDI methodology extends the experiment driven 
architecture of ML-Flex by enhancing it with ontologies that specifies the experiments 
with necessary and sufficient conditions.  Generating the inferred models from the base 
ontology plays a crucial role in annotating samples into novel experiments.  By relying 
upon the logical definitions and the reasoner, the user is able to integrate various GEO 
samples in order to create annotated experiments that can be analyzed in silico.  These 




Experiment. Figure 7.4 shows how GEO samples, represented as OWL individuals, are 
correctly positioned as members to respective OWL condition classes.  
 
Characterizing DC Maturation Using Naïve Bayes in ML-Flex 
Based on the stopping criteria, the ReliefF ranking method applied to the training 
set resulted in 65 probes out of a total 54,675 probes IDs that were differentially 
expressed between immature and mature DCs. Based on the results from the training 
data, I checked if the 65-feature classifier generalized to the 38-sample hold out test set 
consisting of both mature and immature DCs.  The classifier generalized across the 38 
hold samples that included 11 treatments with a hold out test accuracy of 100%.  All hold 
out untreated and Isotype samples were classified as immature; all hold out IFNα, 
CD40L, anti-FcγRIIB, Schuler, Cytokines, Galectin, Poly(I:C), and LPS/IFNγ samples 
were classified as mature. Figure 7.7 depicts a screenshot of the ML-Flex analysis where 
the performance metrics of the analysis are summarized.  The performance metrics show 
that the number of correctly classified test instances was 38 out of a total of 38.  
 
Probe Level Analysis of DC Maturation Across the Four                                              
GEO Experiments 
The heatmap in Figure 7.8 displays the expression patterns of the 65 probe IDs.  
The probe IDs are clustered according to biological function and pathway information 
obtained from the KEGG database [43].  The probe IDs that did not associate with 
interferon regulatory and inducible genes, Nuclear Factor-Kappa Beta (NF-κB) pathway, 
chemokine signaling pathway, kynurenine pathway, or cell adhesion molecules and ECM 




Table 7.1 shows the total mean for all probe IDs of specific clusters in each 
sample.  Using two-tailed independent-samples t-tests, I compared the mean expression 
patterns for probe IDs in the biological function and pathway clusters for the untreated 
condition against the means of probes in clusters for all other conditions. 
The table shows the treatments in order of increasing expression intensity from 
left to right.  Isotype serves as a negative control that does not mature DCs.  No 
significant difference was observed between the untreated samples and samples treated 
with Isotype.  It is important to note that IFNα successfully matures DCs as measured by 
CD86 mRNA expression; however, the treatment produces significant changes only in 
the interferon regulatory and miscellaneous clusters.  The biomarker genes INDO, 
CD274, and CD44 are of particular interest because of their influence on FOXP3+ Treg 
cells.  In Fig , I use a box plot to compare INDO expression across treatments. 
 
Discussion 
The 65-probe panel clearly demonstrates differences between untreated immature 
DC expression and LPS mature DC expression.  The Isotype, negative control, follows 
the untreated expression pattern, while the LPS/IFNγ treatment has gene expression 
patterns similar to LPS treatment.  The distinguishing features between classical LPS-
matured DCs and immature DCs were expected.  The ReliefF feature selection technique 
ranks the probes based on distinctive differences between untreated and LPS-treated DCs 
[25, 27] and the Naïve Bayesian classifier determines the threshold for the number of 
probes needed to correctly classify the 12 training samples.  
Surprisingly, while the remaining eight maturation treatments display patterns 




using the 65 probes, correctly classified all mature hold-out samples as mature.  The 
classifier did not overfit the data as demonstrated by its ability to correctly predict the 
maturity or immaturity of nineteen hold-out samples in Dhodapkar while being trained on 
only one untreated sample from Dohdapkar (see Figure 7.5). 
When DCs are treated with IFNα as a maturation treatment, NFκB pathway genes 
are downregulated and interferon-related genes have high expression. NFκB2 and 
NFκBIA are downregulated in DCs treated with IFNα; therefore, these genes are 
differentially expressed across DC maturation treatments. The Naïve Bayesian classifier 
identifies IFNα as mature partially due to the high expression values of interferon 
regulatory and inducible genes (Table 7.2).  Interferon regulatory factor 7 and factor 9 
(IRF7, IRF9) mediate IFNα signaling, and the interferon-induced proteins IFI44L, IFI6, 
IFIT5, IFIT3, GBP1, and MX1 make up the maximum total mean expression value for 
the cluster (i.e., 5045) across all the treatments.  
Three biomarkers in my panel, INDO, CD274, and CD44, have been shown to 
increase the induction of Treg cells [71-77].  Recent studies have shown that INDO 
mediates the induction of Tregs through the alteration of TGF-β secretion via tryptophan 
metabolism and the kynurenine pathway [57].  INDO is an enzyme in the tryptophan 
pathway, as is KYNU, and both catalyze tryptophan metabolites.  These metabolites 
increase secretion of TGF-β from DCs, which induces FoxP3+ in CD4+ T cells and 
drives native T cells to become induced Tregs [57, 73].  The overexpression of INDO has 
been shown to induce Tregs rendering immunotherapy vaccines to become ineffective 
[71, 73]. INDO and KYNU are downregulated in DCs that are matured with IFNα, 




maturing DCs.   
The gene CD274 is the ligand to the cell surface membrane protein PD-1, which 
is expressed on the surface of active T cells.  It has been shown to suppress host 
immunity in T-cell lymphoproliferative disorders [75] by promoting the induction of 
Tregs.  CD274 is downregulated in the IFNα treatment of DCs but upregulated in other 
treatments.  This is consistent with my hypothesis that IFNα-treated DCs should have a 
reduced level of molecules that play a role in DC based induction of Tregs.  Bollyky et al. 
show how hyaluronan cross-linked CD44 (downregulated in IFNα treatment) enhances 
production of TGF-β, which promotes FoxP3+ expression and induces Treg function.  
Hence, CD44 is similar to INDO in that it can influence Treg induction through TGF-β 
[57, 76]. 
My work provides a gene probe panel to further explore IFNα maturation of DCs in 
relationship to other maturation treatments. The low expression of INDO, CD274, and 
CD44 in IFNα-treated DCs suggests that IFNα may activate cytotoxic T cells and reduce 
the levels of Tregs.  I have identified potential biomarker targets and mechanisms to 
investigate why IFNα treatments show a measurable immune response in cancer patients. 
Using the 65-probe panel, I identified two mechanisms that suggest ways to increase the 
immune response for better outcomes: maturation of DCs and suppression of Treg 
induction.  The results from Experiment 1 generate a hypothesis of how IFNα can result 
in the downregulation of INDO, affecting the production of TGFβ downstream; therefore, 
inhibiting the induction of Tregs to the tumor microenvironment. This hypothesis can be 




































































































































































   
   











































































































































































































































   
   
   







































   
   
   



























































































































   
   
   
































































































































































































































































































































































































































































































































































































Figure 7.1: In the presence of stimuli (example: IFNα) immature DCs are 
matured. Mature DCs represent certain surface markers that interact with T cell 
markers to generate a T cell based immune system response. In this example, 
the B7 surface marker represents the CD80/CD86 complex. Along with these 























Figure 7.2: In this image, the major components of the asserted ontology are depicted. 
Using equivalency rules associated to cell in vitro and treatment classes generates the 
condition classes. For this experiment, there are two conditions asserted on the 50 
integrated GEO samples. Each sample is asserted as a member under the sample class 
(Shown in Figure 7.4). The specific treatments are asserted under ControlTreatment and 
MaturationTreatment, respectively. Members are identified by purple triangles. The 
images can also be visualized using Onto Graph with the Protégé interface. The PG ETI 














Figure 7.3: This image displays the four GEO experiment that are integrated to generate a 
novel OBDI data set to explore DC maturation across 11 treatments. Treatments in green 
are control treatments and treatments in red are maturation treatments. The numbers in 



































































































































































































Figure 7.5: The samples highlighted in red are treatments used to mature DCs. The 
samples highlighted in green contain samples of immature DCs. The numbers of 
samples are listed in brackets. The highlighted blue box represents the combination 




























Figure 7.6: This figure is an illustration of the inferred model that is established after 
executing the reasoner. Samples denoted by an alphanumeric GSM ID are asserted as 
members to the Sample class but they are not associated to specific conditions or the 
experiment (DCMaturationU133Plus) until the reasoner is executed. The entities 



























Figure 7.7: Snapshot of summary results in ML-Flex for aggregated machine learning 













































































































































































































































































































8. EXPERIMENT 2: CLASSIFICATION OF T CELL SUBTYPES 
In Experiment 2, GEO was queried for data that explored the differential 
expression of genes across T cell subtypes. Generating a single panel where T cell 
subtypes are compared may help understand how Tregs are differentially expressed from 
other T cell subtypes. Naturally occurring Tregs have immunosuppressive properties. 
Under normal conditions, they play a key role in maintaining tolerance to self-antigens.  
Tregs have very similar expression patterns to that of other T cell subtypes, i.e. CD4+ 
[56].  What differentiates them from other T cell markers is the expression of the 
transcription factor, FoxP3 [56, 78].  Treg activity is crucial in maintaining self-tolerance; 
however, this suppressive activity becomes counterproductive during an immune 
response against tumor cells [79].  
In cancer immunotherapy clinical trials, the use of DC based vaccines has shown 
promising results.  The effectiveness of immunotherapy lies in the fact that treatments are 
based on inducing, enhancing or suppressing an immune response.  The maturation of 
DCs is an important factor for generating immunotherapy vaccines; however, the 
suppressive activity of Tregs impedes the effector function of immune system cells.  It is 
imperative to maintain low levels of Tregs when using an immunotherapy vaccine in 
order to achieve an enhanced immune response.  A better understanding of how 
maturation treatments affects Tregs may help identifying potential biomarkers that can be 




generate an effective immunotherapy vaccine, induction of Tregs to the tumor site must 
be suppressed [51, 56].  
The various mechanisms by which mature DCs induce Tregs have been assessed 
in detail.  Since Tregs share similar expression patterns to that of other T cell subtypes, in 
Experiment 2, I decided to explore how Tregs were differential expressed in comparison 
to other T cell subtypes.  For Experiment 2, I focused on the classification of T cell 
subtypes.  To do this, more than one GEO experiment must be integrated, creating 
another example of how an ontological representation can be used to curate a DataSet 
outside GEO. Ninety-six samples from three GEO Series records were consolidated.  The 
experiments contain conventional T cells (Tconvs: Th0, Th1, and Th2), naïve T cells, 
natural Tregs (nTregs), iTregs, and effector T cells.  In the first study by Prots et al. [78], 
researchers assessed the development of Tregs and compared the gene expression of 
induced Tregs (iTregs) to that of naturally occurring Tregs (nTregs).  The second study 
by Geffers et al. [80] also assessed the gene expression of iTregs when treated with 
different activation agents. The third study by Lund et al. [81], evaluated the differential 
expression of Th1 and Th2 cells in the presence of TGFβ [78, 80, 81].  The purpose of 
combing these three GEO studies was to see if comparing T cell subtypes would provide 




The data integration component to combine T Cell samples is similar to the 
methods in Experiment 1. The components that are unique to Experiment 2 are explained 





An ontology is created for each experiment to reflect the different parameters 
used to annotate each experiment; however, the framework for the ontologies is 
generalized.  Each ontology uses the same set of OWL classes and OWL object 
properties.  The cell ontology is imported and each ontology is provided a framework 
that includes prior knowledge.  However, the prior knowledge information used to build 
the subclasses varies according to cell types, treatments, and machine learning conditions.  
1. Steps 1 thru 4, and 8 are same as Experiment 1.  Since the framework is 
generalized, specific methods to disjoin classes and adding samples as instances 
are not repeated.  
2. The OWL class PBMC is added as a subclass to cell in vitro.  Since this 
experiment deals with T cells, purifiedTCell is added as a subclass to PMBC.  The 
T cell subtypes are defined under the purifiedTCell class using surface markers.  
Under the CD4-positive_CD25-negative subclass, undifferentiated T cells, Th0, 
Th1, Th2 are defined.  Under the CD4-positive_CD25-postive, effector T cells, 
nTregs and iTregs are defined.  
3. The treatment contains a subtype TCellTreatment.  The T cell treatments used in 
Experiment 2 are control treatments and treatments used to generate specific T 
cell subtypes.  These subclasses have individuals associated to them as OWL 
members.  The Control subclass has one member, untreated.  The 
inducedTregTreatment also has one member, IL4.  The naturalTregTreatment has 
two members: antiCD3+antiCD28 and antiCD3+TR66+IL2.  The members of 




antiCD3+antiCD28+IL12, antiCD3+antiCD28+IL4, antiCD3+TR66+IL2 and 
TGFβ. 
4. The subclasses defined under the condition OWL class for Experiment 2 are 
conventionalTcells, naïveTcells, Teffs, and Tregs. 
5.  Sample is the final class that completes the base ontology.  Experiment 2 
annotated from this ontology is a subclass of ML-Experiment. 
TCellClassificationAffyU133A contains equivalency classes associated by all four 
conditions separated with or limitation.  
Similar to Experiment 1, the asserted ontology for the TCellClassificationAffyU133A 
experiment is displayed in Figure 8.1. 
 
Acquire Data 
The GEO Series records in Experiment 2 are analyzed in a different Affymetrix 
Platform; however, they are stored in the same format as Experiment 1.  The GEO Series 
records for Experiment 2 are: GSE24634, GSE13017, and GSE2770 (see Figure 8.2). 
 
Organize Data 
The steps to organize the data do not change for Experiment 2.  The only 
observed change was that GSE13017 and GSE2770 contained samples analyzed in 
different Affymetrix platforms.  Since this was handled when parsing the XML file and 
building the ontology, multiple platforms did not alter the methods. Figure 8.3 is an 









  Same as Experiment 1. 
 
Analyze Data 
Three machine learning classification algorithms, SVM, Naïve Bayes and 
Decision Tree, were compared to see which is able to successfully differentiate between 
the four T cell subtypes. For each classification method I also perform LOOCV to 
estimate the generalization error.  
Using the Decision Tree algorithm, features are selected using forward selection.  
The ReliefF Ranking method is used to rank features that best aid in informing the 
classification accuracy.  Based on the classification algorithm that performs the best, the 
data that contain the reduced feature set are analyzed.  Once the optimum accuracy is 




 Similar to Experiment 1, the inferred ontology is generated using the HermiT 
reasoner.  Due to scaling purposes, only a few samples for each condition are shown in 
Figure 8.4. 
 
Analyzing Complete Data Sets In Experiment 2  
Using ML-Flex 
In Experiment 2, three machine learning algorithms were compared in order to 
accurately classify the T cell subtypes.  The 96 samples contain four different types of T 




variables that denoted by a probe ID.  The conventional T cell subset includes Th0, Th1, 
and Th2 cells; there are 58 samples in that category.  There are 11 naïve T cell samples, 
16 samples of Tregs, and 11 samples of effector T cells.  The confusion matrix is used to 
check whether each machine learning class was correctly predicted.  When classes were 
not accurately predicted, the confusion matrix allows for the identification of which 
samples were misclassified.  In this ML-Experiment, predictions can be made using the 
different machine learning algorithms, and this is accomplished by using the ensemble-
learning methods implemented in ML-Flex [64].  
Next, the seven ensemble-learning methods were compared to see which 
ensemble method was able to accurately classify the T cell subtypes (described in the 
OBDI, A Novel Pipeline chapter).  In this experiment, three machine learning algorithms 
are specified in the settings; hence, ensemble learners will aggregate across the three 
learners.  The ensemble-learning method in ML-Flex combines individual predictions to 
generate a single prediction. For this analysis I first evaluate the results based on the 
individual algorithms.  A detailed summary of each analysis is stored in the result folder 
and can be accessed using a web browser.   
When all the features (22,283) are included in the analysis, SVM and Select Best 
Ensemble Learners perform better than the other machine learning algorithms 
implemented in the analysis. Figure 8.5 shows the classification accuracy of the machine 







Probe Level Analysis of T Cell Subtype Classification Across                                       
Three GEO Experiments 
The SVM algorithm was used to select a subset of features that are differentially 
expressed in five T cell subtypes: naïve T Cells, undifferentiated T Cells, Tconvs, Tregs 
and Teffs.  Feature selection is performed using SVM, Naïve Bayes and Decision Tree.  
The optimum classification accuracy is achieved by using fewer attributes when SVM is 
used to perform forward selection.  
The differential expression of the 123 features does not change vastly between 
naïve T cells and undifferentiated T cells. When comparing the differential expression of 
genes across two Treg cell subtypes, nTregs and iTregs, the expression of all genes are 
upregulated in iTregs; although the expression patterns between the two subtypes are 
very similar.  The Treg subtypes in this analysis included nTregs and iTregs, both of 
which express the CD25 cell surface marker.  However, iTregs are induced peripherally, 
outside the thymus, and unlike nTregs, do not necessarily require the costimulation of 
CD28 for their development and function [82].  Furthermore, the expression patterns 
between Teffs and iTregs largely overlap, thus it is difficult to determine differential 
expression between the two subtypes. Both Teffs and iTregs express CD25 markers on 
the surface; however, iTregs are treated with IL4 express the FOXP3 transcription factor. 
[78].   
There are several mechanisms that play a role in the induction of Tregs by DCs. 
These mechanisms have been previously discussed in Experiment 1. Vitamin D is one of 
the four mechanisms by which DCs induce Tregs. The active form of Vitamin D, 1a, 25-




downregulating key costimulatory molecules, such as CD80, CD 40, and CD86. The 
receptor of VD3, 1α, 25-dihydroxyvitamin D3 Receptor (VDR), is expressed on many 
immune system cells including T cells. After activation, VDR is present in CD8+ and 
CD4+ T cells [83, 84]. Given that the binding of VD3 and VDR may play a role in the 
induction of Tregs, I compared the expression of VDR across T cell subtypes in Figure 
8.6. Through the meta-analysis performed in Experiment 2, it is evident that the mean 
expression of VDR is higher in iTregs treated with IL4 and Teffs. The binding of VD3 to 
VDR promotes the expression of FoxP3 which is characteristic of iTregs [85].  
Figure 8.6 shows the expression of VDR across T cell subtypes. A two-tailed t-
test is performed to check for the significance of VDR expression between naïve T cells 
and CD 25+ T cells.  When compared to naïve T Cells, the expression of VDR in Teffs 
(p-value = 2.8e-6), and iTregs treated with IL4 (p-value = 9.0e-7) are significantly higher.  
However, when naïve T cells are compared to nTregs treated with IL2, the expression 
VDR does not change significantly (p-values = 0.41). 
 
Interaction of Kynurenine and AHR 
 The elevated expression of INDO in Experiment 1 led to exploring the kynurenine 
pathway and how it may affect other cells in the tumor microenvironment. In the 
kynurenine pathway, Tryptophan metabolized by INDO and kynurenine is the first 
metabolite of this pathway. A further literature review was done to check if kynurenine 
plays a role during antitumor immune system response. The metabolism of tryptophan 
and the generation of kynurenine in the environment is related to the proliferation of 
iTregs. This is mediated by the interaction of kynurenine and the Aryl Hydrocarbon 




of CD25+ FoxP3+ Tregs [86, 87]. However, the lack of AHR in T cells prevents the 
interaction of AHR and kynurenine; therefore, preventing the generation of Tregs. In the 
presence of TGF-β, FoxP3+ Tregs are induced to suppress function of CD4+ and CD8+ 
effector T cells [86]. Although AHR is not part of the feature list, in Figure 8.7 I explore 
the expression of AHR across the T cell subtypes in the integrated OBDI data set.   
 
Discussion 
To continue exploring the hypothesis that surrounds elements in a tumor 
microenvironment, I combined samples that allowed the exploration of how T cell 
subtypes may be differential expressed. The results from Experiment 1 directed a 
hypothesis where DCs have an increased expression of INDO, thus metabolizing 
tryptophan and inducing Tregs by promoting the production of TGF-β. The results in 
Experiment 1 also lead to other markers that play a role in DC based induction of Tregs, 
such as, CD274.  
The samples that were combined in Experiment 2 were based on a targeted 
hypothesis generated from the results in Experiment 1. When the combined samples from 
Experiments 2 were analyzed in silico, VDR was present as part of the 123 feature 
selected list.  The results show that there are high levels of VDR expressed in Tregs 
treated with IL4 as compared to naïve T cells and Tconvs.  
I also explore the expression of AHR across T cell subtypes. AHR plays a role in 
inducing Tregs by interacting with a specific ligand, kynurenine, the first metabolites 
generated by the breakdown of tryptophan by INDO. It is observed that CD4+ Th cells 
treated with TGF-β have a higher mean expression of AHR compared to iTregs treated 




laboratory environment where IL2 or IL4 is added as a secondary treatment to reduce the 
expression of AHR in T cells; therefore, inhibiting the interaction of kynurenine and 
AHR.  
It is evident that the metabolism of tryptophan mediated by INDO through the 
kynurenine pathway plays a role in negatively regulating the immune system response in 
a tumor microenvironment [86-88]. Using OBDI to integrate data across GEO 
experiments allowed us to generate and investigate this hypothesis using in silico analysis. 
The expression of AHR in T cells treated with TGF-β shows that these cells may have a 








































































































































































































































Figure 8.2: The samples highlighted in green are native T cells that do not 
contain any stimulants. The samples highlighted in brown are Tconvs treated 
with specific stimulants that allow for differentiation of T cells. The samples 
highlighted in red represent natural and induced Tregs. Finally, effector T cells 
(Teffs) represent a population of cells that are CD25+ but are not of regulatory 
function. LOOCV is used to analyze the samples; therefore, a hold-out test set  




































































































































Figure 8.4: Inferred ontology generated for Experiment 2. On the left, 15 samples are 
shown before they were reasoned into specific conditions. This is done across 96 samples 















Figure 8.5: ML-Flex makes it easy to compare the performance of different algorithms. 
Each machine learning algorithm is separately assessed to evaluate how the algorithms 
perform in predicting T cell subtypes. The performances of the ensemble methods are 
























Figure 8.6: This image explores the expression of VD3 across T cell subtypes. The 
expression of VD3 is higher in samples that express CD25+ on the cell surface. These 
include samples of nTregs, iTregs treated with IL4, and Teffs. A two-tailed t-test is 
performed to check for significance. 
Figure 8.7: The average expression of AHR is plotted across T cell subtypes. It is noted 
that T cells treated with TGF-β have a higher expression of AHR versus T cells treated 
with IL2 and IL4. 
  
 
9. EXPERIMENT 3: CHARACTERIZATION OF                                              
CANCER CELL LINES 
 
To further evaluate the components of a tumor microenvironment using OBDI, I 
included samples from comparing the gene expression across cancer cell lines. These 
samples were analyzed on a different gene expression platform; therefore, generalizing 
OBDI to other microarray platforms. Based on the meta-analysis in Experiment 1 it was 
evident that INDO was differentially expressed in DC treated with different maturation 
stimuli. The metabolism of tryptophan through the kynurenine pathway plays a role in 
inducing the Tregs; thus, inhibiting the maturation of DCs and CD 8+ T cells. This causes 
the DC-based vaccine to be ineffective. However, when comparing the maturation 
treatments in Experiment 1, it was noted that IFNα successfully matured DCs but the 
expression of INDO was downregulated in DCs treated with IFNα. This led to setting up 
the hypothesis for Experiment 3.  
Relating a specific DC maturation treatment, IFNα, to clinical research where 
cancer cell lines are treated with IFNα at different time points, makes OBDI an effective 
tool to analyze data in translational research. It has been documented that the use of IFNα 
in conjunction with chemotherapy and cancer vaccines overcomes tumor-induced 
immunosuppression by improving the outcome of immunotherapy [89].  Using IFNα as 
an adjuvant therapy has been show to improve disease free survival in patients with high-




macrophages.  In patients with high-risk melanoma, IFNα is the only adjuvant therapy 
that is currently approved.  IFNα had antitumor effects in preclinical and in clinical 
models; however, the mechanistic approach of how IFNα treatment results in an 
antitumor response is not well understood [91-93].   
 
Methods 
To better understand how IFNα plays a role in antitumor response, meta-analysis 
was performed on 10 cancer cell lines treated with IFNα.  Exploring the immune system 
response across cellular and disease states gives a more comprehensive understanding of 
immune system response in a tumor microenvironment. For Experiment 3, I queried GEO 
for specific experiments where cancer cells were treated with IFNα2a. To explore how 
genes may be differential expressed in cancer cells treated with IFNα2a, a GEO 
experiment where four cancer cell lines were treated with IFNα at different time points 
was analyzed through the OBDI pipeline. 
 
Build Ontology 
1. Steps 1-4, and 8 are same as Experiment 1.  Since the framework is generalized, 
specific methods to disjoin classes and adding samples as instances are not 
repeated.  
2. The OWL class cancer_cell_lines is added as a subclass to cell in vitro.  Since 
Experiment 3 deals with the differential expression across melanoma cell lines, 
the cell type information is acquired from the paper associated to the GEO Series 
record [94]. Subclasses to cancer_cell_lines are colon, melanoma, lung, and 




3. The treatment contains a subtype CancerCellLineTreatment.  The treatments used 
in Experiment 3 are control and experimentalTreatment.  These subclasses have 
individuals associated to them as OWL members.  The control subclass has one 
member, control_medium.  The experimentalTreatment has two members: IFNα-
2a_24Hr and IFNα-2a_4H. 
4. The subclasses defined under the condition OWL class for Experiment 3 are 
based on the tissue of origin: colonControl, colonIFNα-2a, endothelialControl, 
endothelialIFNα-2a, lungControl, lungIFNα-2a, pancreasControl, and 
pancreasIFNα-2a.  
5.  Sample is the final class that completes the base ontology. 
CancerCellLineComparisonIlluminaBeadchip contains equivalency classes 
associated by all eight conditions separated with an “or.”  The asserted ontology is 
displayed in Figure 9.1. 
 
Acquire Data 
The third platform used to validate the OBDI methodology is the Illumina 
Expression BeachChip.  Data from a single melanoma experiment are preprocessed and 
organized for machine learning analysis [95].  The GEO Series record used in 
Experiment 3 is GSE 21158 (see Figure 9.2).  
 
Organize Data 
Organizing the melanoma GEO samples vary since the experiment was analyzed 
using the Illumina Expression BeadChip.  The previously described Affymetrix platform 




technology uses microscopic beads that are associated to a specific probe.  To further 
explore the immunological space of cancer immunotherapy, I chose to focus on 
expression array samples where different melanoma cell lines are treated with Interferon-
alpha (IFN-alpha).  There are 10 different melanoma cell lines that are treated with 10 
U/ml IFN-alpha for 4 hour and 24 hours, respectively. Each cell line has associated 
control samples that were not treated with IFN-alpha.   
 
Process Data 
The samples retrieved from GEO experiment, GSE21158, were normalized using 
quantile normalization [63].  The data were downloaded to the pipeline by interfacing 
with Gene Pattern.  Once data were available locally, each sample was separated into 
columns and stored as an individual file.  The samples are organized using the ontology 
and the metadata XML file. 
The sample for each experiment is formatted differently in GEO because of the 
platform specification used to generate the high throughput data.  In order to perform 
meta-analysis for the Illumina BeadChip experiment, the data are directly imported into a 
Gene Pattern module.  Unlike the samples analyzed from the Affymetrix chip, individual 
samples from the Illumina BeadChip GEO experiment cannot be downloaded.  The 
GEOImporter module downloads the experiment from GEO and the file is temporarily 
stored in the Gene Pattern file format [10].  When using Gene Pattern to process samples, 
an annotation file, like the clm file, can be used to annotate the GSM IDs with 
appropriate machine learning conditions.  However, The GEOImporter module does not 
account for an annotation file, like the clm file. To account for this, I incorporated an 




condition.  The annotation is created using the reasoned OWL file for the experiment 
labeled CancerCellLineComparisonIlluminaBeadchip.  Although the GEOImporter 
module does not allow for the replacement of GSM IDs with machine learning 
conditions, it simplifies data processing and acquisition by creating a gct file that contains 
all samples from the melanoma experiment, GSE20156.  The same method is used to 
covert Gene Pattern gct files into ARFF files. Once the ARFF file is generated, meta-
analysis can be performed using ML-Flex. 
 
Analyze Data 




Inferred ontology serves as a backbone for allocating appropriate samples into 
their respective machine learning conditions.  This is done in a standardized way since 
the various parameters of a GEO Series record are store as OWL entities. Figure 9.3 




Machine learning analyses similar to Experiment 2 are performed using the 
cancer cell line data.  The full data set was used to analyze 90 cancer samples using 
individual machine learning algorithms and ensemble learners.  Without performing 
feature selection, the ensemble learners and SVM perform better than Naïve Bayes or 




selection is used on the 90 samples. The meta-analysis for Experiment 3 did not yield 
high classification accuracy, and the feature list contained an extensive list of genes.  In 
the ensemble learning methods, mean probability and weighted mean probability 
performs poorly with the highest classification accuracy (64.4%). SVM classifier also 
performs poorly with an accuracy of 63.3%.    
 
Probe Level Analysis of Cancer Cell Lines 
Feature selection was performed using the ReliefF ranking method using three 
different classification algorithms: Naïve Bayes, Decision Tree, and SVM.  The SVM 
algorithm was used to perform forward selection.  The feature list was reduced to 1304 
attributes and the accuracy for all three algorithms increased to 80%. 
The extensive feature list was searched for any genes that may be related to the 
mechanisms involved in the induction of Tregs, revealing kynureninase (KYNU) as part 
of the feature list. KYNU is part of the kynurenine pathway that breaks down kynurenine 
during tryptophan metabolism. Figure 9.5 depicts the expression of KYNU compared in 
melanoma cell lines and across treatment time points. The results indicate that when 
melanoma cell lines are treated with IFNα2a from 4 hours, the expression of KYNU is 
significantly higher (p-value = 1.47E-4) than samples treated with IFNα2a from 24 hours. 
The expression pattern of KYNU in melanoma cells treated with IFNα2a for 24 hours is 
similar to untreated melanoma cell lines (control).  
 
Discussion 
From the analysis performed in Experiment 1, it was evident that INDO plays a 




expression in DCs treated with different maturation stimuli. To promote translational 
research in the field, cancer cell lines treated with IFNα2a are analyzed using OBDI. 
IFNα2a is similar to the IFNα treatment used to mature DCs, while downregulating the 
expression INDO. These findings were supported by the integrated analysis made 
possible by using OBDI.    
To overcome tumor-induced immunosuppression, IFNα can be used as an inducer 
of DCs in cancer vaccines [89]. Injecting patients with IFNα-matured DCs in conjunction 
with chemotherapy is designed to suppress Tregs, while creating an environment for DCs 
to take up antigens and present them to T cells in lymph nodes.  Patients treated with 
adjuvant IFNα-2b who had a measurable autoimmune response had higher probability of 
relapse-free survival, as well as a higher probability of overall survival [92]. The 
suppression of Tregs is important in the effectiveness of DC based vaccines; however, an 
enhanced CD8+ T cell response has been observed in stage IV melanoma patients 
vaccinated with melanoma-associated peptides near local lymph nodes, in conjunction 
with adjuvant IFNα injections [91]. 
Kynurenine is metabolized by INDO in order to drive the metabolism of 
tryptophan. The in silico analysis in this experiment generated an extensive feature list 
where, KYNU, an enzyme that breaks down kynurenine, was differentially expressed in 
melanoma cell lines treated with IFNα2a for 4 hours and melanoma cell lines treated with 
IFNα2a for 24 hours. KYNU plays a role in the further breakdown of kynurenine into 3-
Hydroxyanthranilic Acid (3-HAA). A treatment of 3-HAA has shown to drive the 
production of TGF-β; therefore, inducing Tregs mediated by the production of TGF-β [57, 




inhibiting the antigen dependent proliferation of CD8+ T cells [96]. When melanoma cell 
lines are treated with IFNα2a a longer time point (24 hours), the expression of KYNU is 
reduces. Lower expression of KYNU can affect the production of 3-HAA and thereby 
reducing the production of TGF-β in the tumor microenvironment. A reduced amount of 
TGF-β may inhibit the proliferation of Tregs.    
The in silico findings from analyzing cancer cell lines can lead to designing 
laboratory experiments to further explore the role of tryptophan metabolism via the 


















































































































































































Figure 9.2: In Experiment 3, there are 90 samples that can be classified into 
four different cell lines. Each cell line is treated with IFNa2a for 4 hours and 































































Figure 9.3: The inferred ontology displays how samples are added to specific conditions 


































































































































































































































10. EXPERIMENT 4: RNA-SEQUENCE DATA ANALYSIS 
The fourth experiment was chosen to explain how data from RNA-Seq 
experiments can be successfully analyzed using OBDI. Differential expression analysis 
is widely performed using microarrays and beachip; however, RNA-Seq is gaining 
popularity among researchers interested in performing differential expression analysis. 
RNA-Seq experiments require lesser quantity of RNA to run the laboratory experiments 
and produce results with higher sensitivity. RNA-Seq analysis can play an important 
role in discovery-based experiments. In order to make the OBDI pipeline up-to-date, it 
was important to explore how RNA-Seq could be incorporated within the pipeline.     
Methods of genomic and mutation analysis have given us a better understanding 
of cancer genetics, but they provide limited insight on mRNA-based interpretation 
during tumorogenesis [98, 99].  Gene fusions are commonly associated with cancers, 
where two previously separate genes come together.  They can occur due to 
chromosomal activities such as: translocations, insertions, deletions, and inversions [95].  
The sequencing of short reads can recapitulate microarray expression predictions and 
also provide additional information that cannot be obtained by microarray 
methodologies.  Sequencing short reads can provide thorough information about the 
existence of spliced variants, which occur during a regulated process where parts of an 




RNA sequencing (RNA-Seq) is a high throughput methodology used to 
sequence the cDNA [102]; whereas, microarrays are tools used to analyze gene 
expression. Compared to microarray technologies, RNA-Seq has higher sensitivity, 
requires smaller amounts of RNA and has a larger dynamic range which can contribute 
to differential expression analysis [100].  
Since the OBDI pipeline was developed to integrate and process high 
throughput data, a GEO experiment, containing a small set of RNA-Seq samples, was 
used as a proof of principle study to evaluate the RNA-Seq analysis integration within 
the pipeline.  There are several modules in Gene Pattern that help with preprocessing of 
sequencing.  These modules are integrated into the OBDI pipeline allowing the user to 
analyze RNA-Seq data.  For this analysis, I focus on RNA-Seq samples analyzed on the 
Illumina Genome Analyzer, where the researchers explored the genetic alterations that 
occur in tumor cells. 
 
Methods 
The GEO experiment contains four samples from melanoma cell lines, eight 
samples from patient melanoma derived short-term cultures, and two samples from 
leukemia cell lines.  These samples were analyzed using the Illumina Genome Analyzer 
and the reads were aligned using the Burrow-Wheeler Alignment (BWA) tool and the 
human reference genomes, hg18 [103, 104].  Individual sample files are stored in BAM 
format [103].  
In this experiment, melanoma and leukemia samples are analyzed in silico using 
OBDI.  Melanoma short-term cultures are cell lines created from patient tumors that 




cell lines proliferate readily under laboratory conditions [105] and passages refer to the 
splitting of cultures to allow cells to continue growing.  Passages refer to the numerous 
cell divisions that occur during cell culturing.  In Giricz et al, researchers proposed that 
multiple passages might contribute to subtle genomic modifications that may occur 
during cell culturing.   
RNA-Sequencing technologies are currently being used in conjunction with 
microarray experiments.  The processing of RNA-Seq samples varies significantly; 
however, the RNA-Sequencing processing module in OBDI can be used to process and 
analyze RNA-Seq data. 
 
Build Ontology 
1. Steps 1-4, and 8 are same as Experiment 1.  Since the framework is generalized, 
specific methods to disjoin classes and adding samples as instances are not 
repeated.  
2. The OWL class cancer_cell_lines is added as a subclass to cell in vitro. Since 
this experiment deals with the differential expression across melanoma cell 
cultures, the cell type information is acquired from the paper associated to the 
GEO Series record [95].  Subclasses related to cancer_cell_lines are: blood, and 
skin. Four cell lines are defined under both subclasses (See Figure 10.1).  
3. The treatment contains a subtype CancerCellCulturePassage.  The treatments 
used are based on the number passages involved during cell culturing.  Each 
subclass has one OWL individual associated as a member.  The controlLeukemia 
and controlMelanoma subclasses have one member, GreaterThan30.  The 




4. The subclasses defined under the condition OWL class are 
LeukemiaNormalPassage, MelanomaNormalPassage, and MelanomaShortTerm.  
5.  Sample is the final class that completes the base ontology.  MelanomaRNA-Seq 
contains equivalency classes associated by all three conditions separated with an 
“or.” The asserted ontology is displayed in Figure 10.1. 
 
Acquire Data 
To develop this part of the pipeline, the entire GEO experiment file is 
downloaded and processed to reveal the individual BAM files.  The method of 
preprocessing the files is similar to how the Affymetrix samples from previous 
experiments were handled. Figure 10.2 displays the samples that are encoded into the 
ontology and used to perform analysis using OBDI.  
 
Organize Data 
Methods are the same as Experiment 1.  Instead of handling cel files, BAM files 
are organized.  
 
Process Data 
Once the BAM files are extracted, Gene Pattern modules are incorporated into 
the pipeline.  There are several tools available for the analysis of RNA-Seq data.  There 
are modules in Gene Pattern that incorporate some of the major tools used in RNA-Seq 
analysis: Bowtie, BWA, Cufflinks, and TopHat [10].  
Since the data are already in BAM format, Cufflinks was used to generate the 
Fragment Per Kilobase of exon Million fragments mapped (FPKM) values for each 




be used to test for differential expression for RNA-Seq samples.  To execute this 
module, users must provide a Generic Feature Format (GFF) or a Genome Annotation 
File (GTF).  These files aid in the assembly of RNA-Seq samples into transcript reads 
[107], which allow for the annotation of RNA-Seq samples at the level of gene 
information [10, 107].  The human GTF files are provided with the OBDI tool; however, 
if researchers use the RNA-Seq module to analyze other organisms, the GFF files can 
be accessed via Gene Pattern [10].  The RNA-Seq fragment counts can be used to 
measure the relative abundance in FPKM values [106].  
Finally, Gene Pattern also contains modules that allows for creating gct files 
from the FPKM values [10].  This provides users with the familiar tab-delimited file 
that has been generated in the previous experiments.  Since there are 14 gct files created 
for each sample, this module requires preprocessing to combine the samples into a 
single matrix.  Once this achieved, the generalize code converts gct files to ARFF files 
that can be used.  The RNA-Seq samples can now be analyzed in ML-Flex to perform 
machine learning analysis.     
 
Analyze Data 





Similar to the previous experiment, the purpose of the inferred ontology was to 




conditions.  There were two melanoma cell lines in Experiment 4 that were grouped 
together under one condition.  To reason the ontology accurately, it was important to 
add both cell line information in the equivalency class of the specific condition. Figure 
10.3 shows how the samples are inferred into the right conditions based on the rules 
defined for the condition class.  
 
ML-Flex Results 
Machine learning analysis on the calculated FPKM is plotted in Figure 10.4. 
Mean probability performs the highest with an accuracy of 76.9% and J48 performs the 
lowest with an accuracy of 46.2 % classification accuracy.  The SVM algorithm is used 
to perform feature selection along with the ReliefF ranking method.  The SVM 
algorithm performs with an accuracy of 69.2% when no feature selection is performed. 
Feature selection is performed using SVM along with the ReliefF ranking method. 
When twelve features are selected, the classification accuracy increases to 84.6%. 
INDO was not part of the feature selected list; however, I evaluated the FPKM values. 
The FPKM values for INDO remained 0 across all samples; however, the FPKM value 
does increase in short-term melanoma samples that underwent 14 passages.  In samples 




RNA sequencing analysis plays an important role in providing insight to 
researchers who are exploring the genetic modifications that occur in a tumor 




representations, I am able to make OBDI pipeline flexible to the continuing growth of 
genomic data. The analysis done using ML-Flex shows that RNA-Seq data can be 


































Figure 10.1: This figure shows the asserted ontology that is developed to 
analyze RNA-Seq data from melanoma cell lines that are cultured for a short 
term in a laboratory setting. The framework of the ontology is similar to that 

















Figure 10.2: Experiment 4 serves as a proof of principle analysis. RNA-Seq 























Figure 10.4: Accuracies of machine learning algorithms and ensemble learners.
Figure 10.3: The inferred ontology used in Experiment 4. 
  
 
11. DISCUSSION  
OBDI is successfully used to integrate and analyze data across GEO 
experiments. OBDI is used to mobilize data in studies that exist in silos. Only 6% of 
samples in GEO are integrated into curated DataSets, allowing the opportunity to 
generate methods that aid the process of data integration across GEO experiments. 
OBDI is a pipeline that aids with the process of combing GEO samples; thereby, 
promoting knowledge discovery by perform analysis on combined studies.  
  The OBDI pipeline reduces the barrier of data integration by encoding various 
laboratory elements into consistent representation. Using ontologies to combine GEO 
samples allows for generating newly curated OBDI data sets. OBDI helps maintain 
consistency of experiments over time by reasoning over ontologies to preform analysis. 
Changes to the analysis for each OBDI experiment can be made by directly altering 
individual ontologies. For instance, the incorporation of ML-Flex allows user to explore 
a range of algorithms that can be used to perform differential expression analysis on the 
combined OBDI experiments. This allows users to keep relevant information regarding 
the in silico analyses in consistent representations, avoiding opportunities for errors and 
performing robust analysis on the integrated sets.     
Adding new samples from GEO can extend the current OBDI experiments. As 
data exploring the field of cancer immunotherapy increases in GEO, sample information 
can be added into the ontology; thereby extending the number of samples integrated and 




questions by changing the domain knowledge of interest. Generalizing the methods in 
OBDI can help generate testable hypothesis for different biomedical research domains.  
Using OBDI to integrate samples that previously existed in silos allowed me to 
generate a hypothesis that can drive research at the bench. Based on the results from 
Experiment 1, the expression of INDO across DC maturation treatment allowed me to 
explore the involvement of the kynurenine pathway during immune system response 
[97]. The downregulation of INDO in DCs treated with IFNα led to exploring the 
treatment of cancer cell lines with two time points of IFNα2a. Although these studies 
were available in GEO, without the use of OBDI, it would be difficult to integrate these 
samples and create in silico experiments that explored the various elements in a tumor 
microenvironment. Figure 11.1 summarizes the findings from Experiment 1-3 that may 
aid in guiding researchers to generate in vitro experiments.  
In Figure 11.1, I propose a testable experiment where tryptophan is not fully 
metabolized; therefore, the metabolites of tryptophan, kynurenine and 3-HAA, are 
present in lower levels in a tumor microenvironment. This may further hinder the 
interaction of AHR and kynurenine and also deplete the environmental concentrations 
of TGF-β. The lack of TGF-β in the environment may prevent the induction of iTregs to 
the tumor site [57]. Since 3-HAA has shown to inhibit antigen specific proliferation of 
CD8+ T cells, the downregulation 3-HAA may help in generating an antitumor immune 
response [96]. Finally, the addition of IFNα in cancer immunotherapy along with 
chemotherapy treatments may help over tumor-induced immunosuppression and 
improve clinical outcomes [89].  Using IFNα as an adjuvant therapy has shown to have 




treatment that can be translated to a clinical setting and the IFNα treatment on 
melanoma patients has proven to be successful in disease free survival [92, 93].  
The immediate application of OBDI can be seen at the bench; however, the 
pipeline can be used to translate hypothesis that can drive experiments in clinical 
research. OBDI can help researchers create direct experiments because it increases the 
power of knowledge discovery by exploring the data across multiple studies.  
 
Limitations 
Since integrating data across different experiments is a complex process, there 
are limitations in the current OBDI methodology.  Building ontologies is a complex 
process; however, the OBDI pipeline does add several OWL components directly into 
the ontology by parsing the GEO metadata.  The first limitation of using OBDI is that 
there is a break between adding OWL elements and generating the final set of results 
using ML-Flex.  OBDI can be executed by using two command line options.  The first 
option allows for adding the various OWL components to the ontology.  Once the 
entities are added, users must add relationships between OWL entities using an 
ontology editor, like Protégé.  This task has been simplified because the metadata are 
added into the ontologies and will guide users to build the correct OWL relationships.  
The second command line option allows users to store the combined the data in the 
local directory, process and run the machine learning analysis on the integrated OBDO 
experiments. The second limitation is the sample size in each individual experiment.  
Due to the specificity of the biological problem assessed, finding relevant GEO 
experiments was a challenging task.  When integrating biological data and generating a 




experiments.  However, as research in the field progresses, more data from GEO or 
research laboratories can be integrated using OBDI to create new experiments. The 
sample size of the integrated OBDI experiments will grow, as more samples are made 
available.   
 
Future Work 
 OBDI can be used to incorporate other high throughput data from different 
repositories. This also allows users to explore data that is being generated in different 
biological domains.  As more samples are incorporated from different repositories, the 
current modules in OBDI must be expanded to other microarray and genomic platforms.  
GEO is the only database that is currently incorporated in OBDI.  Other 
databases store high throughput data that can easily be incorporated into OBDI.  The 
pipeline requires a link associated to the raw data and the supporting metadata.  
 
Relevance to Biomedical Informatics 
OBDI offers immediate support at the bench by aiding users to generate testable 
hypothesis at the bench. The results at the bench can be translated to clinical settings. 
Combining samples across GEO experiments can be challenging but integrated sets can 
provide insights that were previously overlooked  
In the field of biomedical informatics, translational research is a growing 
component where researchers are eager to incorporate the findings of a biomedical 
research directly to patient care.  The goal of this project was to provide support for 
bench researchers to better understand the molecular mechanisms involved during an 




immunotherapy vaccine development and support the development of new insights in 









































Figure 11.1: This image displays the possible application of IFNα to generate a 
successfully antitumor immune response. The diagram also displays a hypothesis that can 




Only 6% of samples in GEO are manually curated GEO DataSets and the backlog 
hinders the ability to find new insights from the vast repository of studies. OBDI serves 
as a solution to combine data across GEO experiments and increase the power of 
knowledge discovery through high throughput data. The OBDI pipeline incorporates 
several bioinformatics methods, specifically related to ontologies, data processing and 
analysis. Ontologies serve as the framework for storing metadata elements and the in 
silico analysis elements used to conduct machine learning analysis. The OBDI pipeline 
uses ontologies to annotate and augment experiments from publicly available repositories 
(e.g., GEO). Using the ontological framework, samples are successfully organized across 
different GEO experiments.  The ontological framework within OBDI allows researchers 
working in a particular biomedical domain to store high throughput data elements and 
organize samples across different GEO experiments. The use of ontologies reduces the 
barrier to integrate new studies into the meta-analysis. Reasoning over ontologies helps 
maintain consistency of the OBDI experiment structure as more samples are added to 
current OBDI experiments. Using the OBDI pipeline, researchers can mobilize data that 
exists in silos to help generate testable hypothesis at the bench. 
OBDI’s ontological representation promotes the integration of complex data and 
prior knowledge. The new annotation from this dissertation extends the current biological 




silico machine learning experiments were conducted that explore the mechanism of 
cancer immunotherapy at a molecular level. Each experiment focuses on different cell 
types. The OBDI pipeline supports researchers’ ability to create predictive models that 
may lead to new hypotheses. For example, I used OBDI to manage the results from 
Experiment 1 and generated a hypothesis around the maturation of DCs and mechanism 
by which mature DCs induce Tregs. When characterizing the maturation of DCs, the 
expression of two genes, INDO and KYNU, was assessed across DC maturation 
treatments. It was discovered that the expression of INDO and KYNU is down regulated 
in DCs treated with IFNα.  
These findings are generalized to Experiments 2 and 3 to further explore how the 
induction of Tregs may play a role in cancer immunotherapy.  As extant findings support, 
INDO plays a role in breaking down tryptophan into the first metabolite of the 
kynurenine pathway. Kynurenine interacts with AHR in Tregs, thus causing the 
proliferation of Tregs and suppressing immune system response. The IFNα treatment 
from Experiment 1 generalizes to Experiment 3, where the expression of cancer cell lines 
was treated with IFNα2a for 4 and 24 hours. KYNU plays a role in generating 3-HAA for 
the release of TGFβ into the environment. It was evident that melanoma cell lines treated 
with IFNα2a for 24 hours have a lower expression of KYNU. The combination of these 
results generate a testable hypothesis where a downregulation of INDO and KYNU may 
lower the production or affect certain tryptophan metabolites; thus, inhibiting the 
suppressive activity of Tregs in a tumor environment. Experiment 4 integrates sequencing 
data that expands the OBDI pipeline to include data beyond microarray experiments. 





Using the OBDI methodology, researchers can generate models and conduct 
laboratory experiments. Through publically available data (e.g., GEO), I am able to 
generate integrated models to help bench researchers understand the immune system at a 
molecular level.  By conducting machine learning analysis, I can compare different 




DATA_PROCESSORS Location where the ARFF or CSV files is stored  
CLASSIFICATION_ALGORITHMS Classification algorithms used for the specific analysis 
FEATURE_SELECTION_ALGORITHMS Feature selection algorithms used for the analysis 
TEST_INSTANCE_IDS 
When preforming testing/training, 
this parameter allows for 
specifying I.Ds that are used to 
testing instances  
TRAIN_INSTANCE_IDS 
When preforming testing/training, 
this parameter allows for 
specifying I.Ds that are used to 
training instances 
NUM_INNER_CROSS_VALIDATION_FOLDS 
List the number of “outer” folder 
while performing cross validation 
(0=LOOCV, 1=Train/Test, 
n=specify the number of 
instances).  
NUM_OUTER_CROSS_VALIDATION_FOLDS 
List the number of “inner” folder 
while performing cross validation 
(0=LOOCV, 1=Train/Test, 
n=specify the number of 
instances). 
NUM_FEATURES_OPTIONS 
Specify the appropriate number of 
features to use in order to 







MAIN_OUTPUT_FOLDER Location where all output files are stored 
GEO_DATA_LINKS GEO links to raw data 
GEO_XML_LINKS GEO links to metadata 
OWL_FILE Location of ontology file 
MASTER_INDEX_FILE Location of master indexing file created by the first part of OBDI 
RAW_FILE_FOLDER Same as MAIN_OUTPUT_FOLDER 
ZIPPED_RAW_FILES Same as MAIN_OUTPUT_FOLDER 
GENE_PATTERN_CLM_FILE Location of CLM file created by the first part of OBDI (Affymetrix Only) 
OPTIONAL_FEATURE_LIST Location of text file containing features to select 
GENE_PATTERN_GCT_FILE Same as MAIN_OUTPUT_FOLDER 
WEKA_ARFF_FILE Same as MAIN_OUTPUT_FOLDER 
MLFLEX_JAR_FILE Location of ML-Flex file 




MASTER INDEXING FILE FORMAT 
The master-indexing file is a text file where each field is separated by a pipe 
character. The general format of the master-indexing file is as follows: 
GSM ID|Title Text related to the GSM ID|ML-Experiment Name|Relevant 
machine learning condition 
Based on the master-indexing file, a TreeMapping method is created that helps 
map each sample to the machine learning condition.  Since GSMxxx identifies the 
samples, the master-indexing file makes it easy to place the GEO samples into the 













SIGNING UP FOR GENE PATTERN 
To create a Gene Pattern account, follow the steps below: 
1. Point your internet browser to the following URL to create a Gene Pattern 
account: http://genepattern.broadinstitute.org/gp/pages/login.jsf 
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